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III. ABSTRACT 
 
Branching morphogenesis of the metanephric kidney relies on an intricate 
molecular system that controls a highly regulated developmental program. 
Metanephric kidney organogenesis involves a complex system of epithelial 
mesenchymal interactions that orchestrate an elaborate epithelial branching 
process. Although it has already been shown that BMP signalling is involved in 
this process the present study reveals the functional importance and relevant 
interactions of BMPs with the antagonist GREMLIN1 (GREM1). Our genetic and 
molecular analysis identifies GREM1 as an essential negative modulator of 
BMP4 signaling during initiation of kidney branching morphogenesis. GREM1 is 
essential for positioning the ureteric bud, initiating its outgrowth and proper 
epithelial branching. GREM1 is not only required to antagonize BMP4 but 
genetic analysis of its interactions with BMP7 reveals a more general role in 
modulating BMP signaling. In light of these GREM1 interactions with BMP4 and 
BMP7, my Ph.D. research indicates that GREM1 orchestrates initiation and 
progression of epithelial branching by establishing spatiotemporal control of 
BMP activity in the mesenchyme surrounding the Wolffian duct, ureteric bud 
and likely also branching epithelium.  
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IV. INTRODUCTION 
 
One important aim of developmental biology is to gain insight into the intricate 
mechanisms that control organogenesis. The main topic of my thesis focuses 
on epithelial-mesenchymal (e-m) feedback signalling during mouse kidney 
development. In this section I will describe the molecular pathways that control 
cell proliferation, patterning and differentiation during mammalian metanephric 
kidney development. Although the central research aim was to analyse the BMP 
(bone morphogenetic proteins) – Gremlin1 antagonistic interactions, modulation 
of the BMP pathway and its interactions with other key molecular pathways was 
genetically and molecularly addressed. The aim of my thesis research was to 
provide insight into the early events leading to the ureteric bud formation and 
initiation of epithelial branching morphogenesis.  
 
Overview of kidney development 
Mammalian vertebrate kidney development reflects evolution of kidneys in 
vertebrates. It recapitulates the transition from the ancestral aquatic 
environment to a terrestrial “dry” niche by formation of a pronephros, 
mesonephros and metanephros. One can say that mammalian kidney 
developmental programmes are in agreement with Ernst Haeckel’s dictum 
“ontogeny recapitulates phylogeny”. This is also illustrated by kidney 
development in mouse, Xenopus and zebrafish embryos (see figure 1; Ohno, 
1995).  
15 
 
 
 
Fig. 1. Early patterning of the mouse, Xenopus, and zebrafish kidneys. (a) One side of the 
developing mouse intermediate mesoderm is shown at approximately E10.5. More anterior, the 
primary nephric duct connects to a series of well-developed mesonephric tubules, and more 
posterior it exhibits a single ureteric bud. The metanephric mesenchyme will generate most of 
the adult metanephric kidney. (b) In the Xenopus embryo, by stage 38, the pronephros is fully 
functional and consists of a glomus that filters into the coelum. Filtrate is reabsorbed by the 
ciliated nephrostomes and passed down the duct. (c) The zebrafish larva has a single midline 
glomerulus filtering from the dorsal aorta. Two bilateral pronephric tubules direct the filtrate 
lateral and caudally down the ducts (from Dressler, 2006).  
 
The murine kidney development is initiated around embryonic day 8.0 as the 
intermediate mesoderm (IM) receives signals from the surface ectoderm and 
gives rise to two lateral paired epithelial ducts, the nephric ducts (ND) (Obara-
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Ishihara et al., 1999). The Wolffian duct (WD) differentiates from mesoderm 
within the ND (reason why ND and WD are often considered synonyms of the 
same structure) and will induce formation of the pronephric and mesonephric 
kidneys/tubules as it extends caudally. Although pronephric tubules are 
functional in fish and amphibian larvae, there is no known function for them in 
mammals. Both the pronephric tubules and the rostral most region of the 
pronephric duct degenerate rapidly. The mesonephric kidney is the second 
kidney type to be formed, but it is also a transient structure that arises caudally 
to the pronephros by E9.0 (Saxen, 1987). As more mesonephric tubules are 
formed caudally, the rostral-most mesonephric tubules start to degenerate. 
Although in humans no evidence for a functional role of the mesonephros has 
been found, the murine mesonephric kidney appears to play an important role in 
the development of epididymal ducts of the male embryo (Sainio and 
Raatikainen-Ahokas, 1999; Saxen, 1987). The development of the definitive 
kidney, the metanephric kidney, is induced at around E10.5. The caudal region 
of the WD starts to swell and the resulting epithelial thickening will form the 
ureteric bud (UB) at the level of the hindlimb (Fig. 1).  
Reciprocal signalling between the metanephric mesenchyme (MM) and the UB 
initiates and maintains metanephric kidney branching morphogenesis (Fig. 2). 
The UB elongates towards the adjacent (MM) and, as this invasion occurs, a 
complex sequence of e-m signalling events induce formation of the collecting 
duct (CD) system, as a consequence of repetitive branching of the UB (Fig.2A; 
Dressler, 2002; Saxen, 1987).  
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After initiation of branching morphogenesis, another important process 
commences. The tips of the branched UB will induce the surrounding 
mesenchyme to condense and form the nephrogenic mesenchyme. The 
nephrogenic mesenchymal cells will proliferate, epithelise and form the renal 
vesicle (Fig.2B). The renal vesicle assumes a primary comma-shape, due to the 
radial plane of cell division to the vesicle lumen, polarization of the renal vesicle 
and cell elongation. Consequently, cells furthest from the collecting duct will 
elongate and additional cell movements will result in formation of a second slit, 
giving rise to an S-shaped structure, whose distal tubule will be inserted into the 
collecting system. At the S-shape stage, cells will differentiate and form the 
Bowman’s capsule, followed by appearance of the first presumptive podocytes. 
When the proximal cleft is invaded by endothelial cells, glomerulogenesis is 
initiated (Fig. 2B and 3A). Nephrogenesis results in formation of the renal 
vesicles, which are the basic units of the metanephric kidney that filter 
hazardous metabolites from the circulating blood and are required to regulate 
the blood water content (Dressler, 2002; Saxen, 1987).  
The nephrogenesis process is reiterated many times and, depending on the 
organism, it will be continued after birth (Hartman et al., 2007). The metanephric 
kidney is composed of hundreds of thousands of nephrons (roughly 1 million 
nephrons per human kidney) giving rise to the glomeruli as already mentioned 
(Dressler, 2002; Saxen, 1987). As the podocytes develop, the blood filtrating 
surface area increases and the metanephric kidney achieves its final and 
complex functional character (Fig.3).   
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Fig. 2. Morphogenesis of the metanephric kidney. (A) Metanephric kidney development 
commences with metanephric mesenchyme (mm) induced out of pocketing of the ureteric bud 
(ub) from the caudal aspect of the Wolffian duct (wd). The ureteric bud then grows towards and 
invades the mesenchyme and begins to undergo dichotomous branching morphogenesis. (B) 
Branching epithelial tips (boxed in A) signal adjacent mesenchymal cells to condense around 
the tip and undergo a mesenchyme–epithelial transformation forming the renal vesicle, comma-
shaped body, and S-shaped body. The S-shaped body is comprised of three segments that 
undergo growth and differentiation to form the fully differentiated nephron. The segment of the 
S-shaped body nearest the ureteric duct (light green colour in S-shaped body and nephron) is 
comprised of distal tubule progenitors (dtp) that ultimately fuse with the collecting duct (cd) and 
become the distal tubule (dt), ascending loop of Henle (alh), and descending loop of Henle 
(dlh). The middle segment of the S-shaped body (medium green colour in S-shaped body and 
nephron) is comprised of proximal tubule progenitors (ptp) and ultimately becomes the proximal 
tubule (pt). The most distal segment in the S-shaped body (dark green colour in S-shaped body 
and nephron) is comprised of glomerular progenitors (gp) that form the glomerular podocytes 
(gp) and Bowman’s capsule (bc). Presumptive endothelial cells (pec) invade the developing 
glomerulus, giving rise to glomerular capillary loops (gcl) and the afferent (aa) and efferent (ea) 
arterioles (from Cain et al., 2008). 
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Fig. 3. Development of the glomerulus. The sequential stages of glomerular development 
are outlined schematically. (a) The S-shaped body is infiltrated by endothelial cells to generate 
a primitive vascular tuft within the cup-shaped glomerular precursor region. (b) The visceral 
epithelial cells, or podocyte precursors, contact the endothelial cells and begin to differentiate. 
(c) The glomerular basement membrane (GBM) is formed at the boundary between podocyte 
and endothelial cells. Podocytes begin to extend primary and secondary foot processes. (d) A 
schematic cross section through a mature glomerulus shows the relationships among the 
capillary endothelial cells, mesangial cells, GBM, and podocytes that are evident at later stages 
and in mature glomeruli. A high-magnification electron micrograph (d, inset) shows a typical 
cross section through the GBM. Note the fenestrated endothelium on the capillary side and the 
interdigitated podocyte foot processes on the urinary space side. Note also the precise distance 
between interdigitations at the slit diaphragm (from Dressler, 2006). 
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Alterations of ureteric epithelial branching morphogenesis will lead to renal 
malformations. Kidney agenesis, dysplasia, cysts formation and reduction of 
nephron number are just some of the many abnormalities observed in several 
human diseases and syndromes (Costantini, 2006). Considering that congenital 
abnormalities of the kidney and urinary tract (CAKUT) occur in about 1 out of 
500 newborns and constitute 20-30% of all anomalies identified during the 
prenatal period (Schedl, 2007), the study of the altered molecular mechanisms 
underlying these anomalies is very relevant to understanding the aetiology of 
these congenital malformation. 
 
Initiation of ureteric bud formation and branching morphogenesis: A 
molecular perspective 
The early events leading to the formation of the metanephric kidney are 
responsible for the future of this crucial organ that contributes to making the 
Mammalia the most developed and advanced class among vertebrates. As 
discussed, metanephric kidney development is initiated as the epithelial UB is 
formed. 
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The GDNF/RET signalling module – the UB outgrowth and branching 
morphogenesis engine 
Our current understanding shows that the glial cell line-derived neurotrophic 
factor (GDNF), its receptor encoded by the proto-oncogene tyrosine kinase RET 
and the co-receptor GDNF-family alpha (GFRα), constitute the main 
components of an engine that drives initiation of the UB, its outgrowth and 
branching morphogenesis (Shakya et al., 2005).  The textbook model indicated 
that mesenchymal cells located in metanephric mesenchyme (MM) secrete 
GDNF, a protein ligand that signals through the receptor RET and its co-
receptor GFRα expressed by the epithelium (Costantini and Shakya, 2006) . 
Recently, it has been shown that Ret expressing epithelial cells are a 
heterogeneous population that will compete and move towards the caudal WD, 
where the ones expressing highest Ret levels will initiate UB formation (Chi et 
al., 2009). However, non-RET expressing cells also contribute to the 
rearrangement of the WD from a simple to a pseudostratified epithelium. In 
addition, paired box gene 2 (PAX2), expressed by the mesenchyme 
surrounding the Wolffian duct (Dressler et al., 1990), is required for GDNF 
activation (Brophy et al., 2001) by enhancing RET activation (Brophy et al., 
2003). Ret and Gfrα are initially expressed along the entire Wolffian duct 
epithelium, but as mesenchymal Gdnf activates this receptor complex, and the 
ureteric bud elongates towards the MM, their expression is up-regulated in the 
UB tip (Shakya et al., 2005; Towers et al., 1998). Branching morphogenesis is 
initiated when the epithelial UB assumes a T shape (Saxen, 1987). The ureteric 
bud branch tips express high levels of Ret, strengthening the GDNF mediated 
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activation (Costantini and Shakya, 2006). Interestingly, inactivation of Wnt11 by 
gene targeting has shown that the embryonic and post-natal kidneys remain 
smaller (Majumdar et al., 2003). That observation together with down-regulation 
of Ret and Gdnf expression showed that WNT11 is required for the propagation 
of the GDNF/RET feedback signalling loop. 
 
Early regulation of GDNF/RET feedback signalling loop 
UB formation and reiterated epithelial branching morphogenesis are tightly 
regulated to prevent misexpression leading to malformations. As mentioned 
earlier, deregulation of GDNF/RET signalling interactions are quite striking (Jain 
et al., 2006). Gdnf, Ret or Gfrα1 inactivation most frequently leads to a failure to 
form a metanephric UB, resulting in complete renal agenesis, although 
rudimentary kidneys may form 30–50% of the time depending on genetic 
background (Costantini and Shakya, 2006; Moore et al., 1996; Schuchardt et 
al., 1996). Genetic inactivation of Ret in mouse results in incomplete kidney 
agenesis, due to a failure of the UB to elongate (Schuchardt et al., 1996). 
Considering the recent findings (Chi et al., 2009), it is possible that the 
previously described variable Ret loss of function phenotype (Schuchardt et al., 
1996) is a consequence of the Ret independent ability of WD epithelial cells to 
rearrange and contribute to the epithelial conversion. Several targets of 
GDNF/RET signalling have been identified: the ERK MAPK, PI3Kinase/Akt and 
PLCγ pathways (Costantini, 2006), the canonical WNT pathway β-catenin 
(Clevers, 2006) and, more recently, a set of ETS transcription factors (Etv4 and 
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Etv5) (Lu et al., 2009), which are themselves required for correct kidney 
epithelial branching morphogenesis. 
Not only is it of importance to enhance GDNF/RET signalling, but restricting the 
location of these interactions is equally important. One gene involved in this 
restriction is Sprouty1 (Spry1), which belongs to the SPRY family of proteins 
that inhibit the Ras-ERK pathway downstream of various receptor tyrosine 
kinases (Fig. 4A; Chandramouli et al., 2008). Inactivation of Spry1 in mouse 
embryos results in formation of supernumerary ureteric buds along the WD (Fig. 
4D-F), which display abnormal/ectopic Gdnf/Ret expression, suggesting that the 
Spry1 mutant phenotype is caused by increased sensitivity of the WD to 
GDNF/RET signalling. This results in formation of multiple ureters and multiplex 
kidneys (Basson et al., 2005). Most importantly, ectopic expression of the 
human Spry2 in the mouse ureteric bud results in down-regulation of Wnt11, 
Gdnf and Fgf7 expression, preventing normal kidney morphogenesis. 
Furthermore, it has been shown that over-expression of Spry2 interferes with 
FGF signal transduction (Chi et al., 2004). Taken together, these results 
indicate that intra-cellular SPRYs are necessary to reduce the sensitivity of the 
WD to GDNF to restrict UB formation to one site (Basson et al., 2005; Chi et al., 
2004). In addition, Slit2 (ligand) and Robo2 (receptor) are also required to 
restrict GDNF/RET feedback signalling to the caudal WD. Slit2 and Robo2 
deficient mutant mouse embryos display abnormal Gdnf expression in the 
anterior nephrogenic mesenchyme that results in the formation of 
supernumerary UBs (Grieshammer et al., 2004). Furthermore, it has been 
shown that forkhead/winged helix gene Foxc1 homozygous mutant mouse 
24 
 
 
embryos present several metanephric kidney abnormalities such as duplex 
kidneys, double ureters and hydroureters, as a consequence of ectopic 
mesonephric tubules and anterior ureteric buds (Kume et al., 2000). 
 
 
Fig. 4. The role of GDNF in ureteric bud formation is modulated by multiple mechanisms. 
Ureteric bud outgrowth from the Wolffian duct is stimulated by GDNF, which is expressed in a 
broad domain of the adjacent intermediate mesoderm (a, red bar and arrows). The Gdnf 
expression domain is restricted by the transcription factor Foxc1 and by Slit2/Robo2 signalling; 
in their absence, it is expanded anteriorly (dashed red box), resulting in ectopic ureteric buds 
(not shown). SPRY1 in the Wolffian duct negatively regulates the response to GDNF (yellow 
symbols). BMP4 suppresses the response of GDNF, and is itself suppressed by GREM1. 
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Together, these mechanisms result in outgrowth of a single, correctly positioned ureteric bud 
(b), and formation of a single kidney (c). Knockout of Spry1 (d) results in the formation of 
multiple ureteric buds (e) leading to multiple ureters and multiplex kidneys (f). Transgenic 
misexpression of GDNF throughout the Wolffian duct (g) overcomes these mechanisms of 
negative regulation and leads to multiple ureteric buds along the entire Wolffian duct (h). Some 
of these ectopic buds connect to the kidney (i, black arrowhead; black arrow points to the 
normal ureter), while others branch outside the kidney (white arrowheads). Inset: continued 
extra-renal branching of ectopic  ureteric  buds  expressing  GDNF (from Costantini and 
Shakya, 2006). 
 
The role of BMP signalling in metanephric kidney development 
In addition to the GDNF/RET interactions described, genetic and molecular 
analysis in mouse embryos has also provided evidence of the requirement of 
BMP signalling during early kidney development and for kidney homeostasis 
(Bush et al., 2004; Dudley and Robertson, 1997; Martinez et al., 2002; Michos 
et al., 2004; Miyazaki et al., 2000; Oxburgh et al., 2005; Zhu et al., 2006).  
 
The BMP signalling pathway 
Bone morphogenetic proteins (BMPs) comprise the largest subfamily of the 
transforming growth factor-β (TGF-β) superfamily of secreted proteins 
(Massagué, 1998). Several members of the BMP family are required for 
mesoderm formation, development and patterning of many different organ 
systems (Hogan, 1996). The involvement of this TGFβ subfamily in biological 
processes such as cell proliferation, apoptosis, differentiation and 
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morphogenesis has triggered a lot of interest in the functions of BMPs during 
development and disease processes (Hogan, 1996; Pregizer and Mortlock, 
2009).  
BMPs are extracellular proteins that have been originally identified as secreted 
factors able to induce ectopic bone tissue formation in vivo (Urist, 1965). The 
BMP family members, like all TGF-β family members, are synthesized as large 
inactive precursor proteins that become active by cleavage of the amino acid 
motif -Arg-Ser-Lys-Arg- yielding a C-terminal mature protein, which forms 
dimers (Aono et al., 1995; Cui et al., 2001). All BMPs, with the exception of 
BMP1, share the highly conserved 7 cysteine knot characteristic of members of 
this transforming growth factor-β family (Fukagawa et al., 1994; Takahara et al., 
1996). Heterodimerization of different BMPs, such as BMP2/5, BMP2/6, 
BMP2/7 and BMP4/7 occurs in vivo and in vitro, and heterodimers are 
functionally more potent than the corresponding homodimers of each of the 
BMP proteins (Fig. 5; Little and Mullins, 2009; Nishimatsu and Thomsen, 1998; 
Sieber et al., 2009). 
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Fig. 5. Model of heterodimer-mediated dorsoventral patterning. Schematic representation 
of the putative interaction mechanism between the postulated BMP-2/7 heterodimers and the 
BMP receptors. Extracellular BMP antagonists bind to the dimerized BMP ligands, preventing 
them to activate the receptor. Following activation of the BMP receptors by a BMP-2/7 
heterodimer, the receptor will phosphorylate the intracellular SMAD proteins. This in turn 
triggers a signalling cascade that initiates BMP signalling transduction (from Little and Mullins, 
2009). 
 
BMP signalling ligands during kidney development 
As previously described, BMP proteins are required during early embryonic 
development for germ layer formation, their inactivation often results in early 
lethality (Hogan, 1996). The initial BMP transgenic and knockout studies 
unveiled the various role of the different BMP ligands in developmental 
processes (Table 1; Cao and Chen, 2005; Hogan, 1996).  
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Table 1 – BMP Ligands Mutant Renal Phenotypes.  
BMP ligands Phenotypes                 
 
BMP2 
 
 
 
 
 
BMP3 
 
BMP4 
 
 
 
 
 
 
 
BMP5 
 
BMP6 
 
BMP7 
 
Homozygous lethal between E7 and E10.5 due to amnion/chorion 
and cardiac development defects. 
 
Heterozygous embryos display an increase of the ureteric bud cells 
proliferation.  
 
No renal phenotype reported. 
 
Homozygous lethal between E6.5 and E9.5 due to early 
mesodermal differentiation defects or late mesodermal derived 
abnormal deficiencies. 
 
Heterozygous display kidney dysplasia phenotypes, including 
hypo/dysplastic kidneys, hydroureters, ectopic ureterovesical 
junction, and double collecting duct system.  
 
Hydronephrosis. 
 
No renal phenotype reported. 
 
Homozygous –null mice display renal dysgenesis, hydroureter 
formation and overall arrested development at E14.5. 
 
 
The initial expression analysis revealed that several Bmp genes are expressed 
early during metanephric kidney development in specific patterns. (Dudley and 
Robertson, 1997). Briefly, Bmp transcripts were detected throughout 
metanephric kidney development in structures such as the metanephric 
mesenchyme, ureter, developing tubules and glomeruli (Dudley and Robertson, 
1997). A schematic representation of the expression patterns of the different 
BMP ligands is shown in Fig. 6. 
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Fig. 6. Metanephric expression of bone morphogenetic protein (BMP) ligands. Transcripts 
for BMP2-7 have been detected during different stages of metanephric development in distinct 
and overlapping domains. This schematic depicts the expression patterns following invasion 
of the metanephric mesenchyme by the ureteric bud at ≈E11.5 (A) and at a later developmental 
stage, ≈ E13.5 (B; from Cain et al., 2008). 
 
Both Bmp2 and Bmp4 deficient mouse embryos are lethal at a very early 
developmental stage (Table 1). Bmp2 deficient embryos die between E7 and 
E10.5 due to amnion/chorion and cardiac defects (Zhang and Bradley, 1996), 
while Bmp4 deficient embryos display variable phenotypes. Some Bmp4 
deficient embryos die due to disruption of mesoderm formation at E6.5 and 
others perish around E9.5 due to developmental retardation with disorganized 
posterior structures and malformed extraembryonic mesoderm (Winnier et al., 
1995). With respect to kidney development, interesting results were obtained by 
analysis of Bmp2 and Bmp4 single heterozygous mice. The Bmp2 
heterozygous mouse embryos displayed an increase in proliferation of ureteric 
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bud cells, although branching morphogenesis was not significantly affected 
(Hartwig et al., 2005). Bmp4 heterozygous mice exhibited several phenotypes 
such as cysts formation, hydronephrosis and glomerulocystic abnormalities 
(Dunn et al., 1997). In addition, Bmp3 and Bmp6 are both expressed during 
kidney development (Dudley and Robertson, 1997) but mutant mice displayed 
no renal phenotypes, pointing to functional redundancy or compensation 
(Daluiski et al., 2001; Solloway et al., 1998). In Bmp5 deficient mice the most 
obvious phenotype affects bones and hydronephrosis is also observed 
(Kingsley et al., 1992). Finally, Bmp7 deficient mouse embryos display 
dysplastic kidneys and hydroureters with an arrest of nephrogenesis at E14.5 
due to lack of sufficient progenitors (Dudley et al., 1995). In summary, 
inactivation of different BMP ligands results in a variety of metanephric 
malformations. Therefore a more detailed analysis of their functions and 
interactions with other morphoregulatory pathways such as the GDNF/RET 
signalling system is required. 
 
BMP receptors 
Not only BMP ligands, but also the BMP receptors, are expressed in partially 
overlapping patterns (Challen et al., 2005). As previously mentioned, BMP 
dimers bind to type I and type II heterodimeric transmembrane serine/threonine 
kinase receptor complexes (Fig. 7; Aono et al., 1995). Thus far, six different 
BMP receptors have been identified that interact with different types of different 
BMP (Nohno et al., 1995; ten Dijke et al., 1994). Type I receptors include Activin 
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receptor type 1A (ActRIa or Alk2), BMP receptor type IA (BRIA or Alk3) and 
BMP receptor type IB (BRIB or Alk6).  
 
Fig. 7. Promiscuity of ligand–receptor interaction. Presentation of the preferential receptor 
usage of particular ligands. Graded differences in the binding affinities of individual ligand–
receptor interactions are indicated (from Nickel et al., 2009). 
 
Type II BMP receptors include BMP receptor II (BRII), Activin receptors type IIA and IIB 
(ActRIIA and ActRIIB; Miyazono et al., 2005). Considering that different BMPs have 
different affinities for the receptors and, in addition, BMPs can either homodimerize or 
heterodimerize with other BMPs, this allows for a possible molecular explanation for 
the variance of phenotypes observed in BMP mutant mice (Hogan, 1996). BMP2 and 
BMP4 bind BRIA and BRIB type I receptors with a high affinity while their affinity to 
type II receptor BRII is rather low (Koenig et al., 1994). Conversely, BMP7 interacts 
with high affinity with the type II receptors ActRIIB and ActRIIB, while its affinity for type 
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I receptors is rather low. Structural analysis of BMP7 reveals the much better affinity of 
the extracellular domain of the type II receptor in contrast to the 5-fold lower affinity for 
type I receptors (Greenwald et al., 2003). The BRII is active as part of a BMP 
heterodimeric receptors complex and upon binding of a BMP ligand, the BRI 
intracellular domain is phosphorylated which results in initiation of BMP signal 
transduction (Fig.8; Derynck and Zhang, 2003; Wrana et al., 1994).       
 
 
Fig. 8. Bone morphogenetic protein (BMP)-mediated signalling pathway. Canonical BMP-
SMAD signalling (black arrows) is initiated by ligand binding to preformed heteromeric receptor 
complexes: a type I receptor (ALK2, ALK3, or ALK6) and a type II receptor (BMPRII). The 
phosphorylated type I receptor in turn phosphorylates a pathway-specific cytoplasmic signal-
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transducing acceptor protein known as a receptor-activated SMAD (R-SMAD) (SMAD1, 5, or 8). 
R-SMADs then form heteromeric complexes with the common-mediator SMAD (Co-SMAD) 
SMAD4 in the cytoplasm and translocate into the nucleus where they interact with other 
transcription factors or regulate transcription of various target genes themselves. Non-canonical 
BMP signalling (red arrows) results in activation of the mitogen-activated protein kinase (MAPK) 
family of signalling molecules and is initiated by ligand-induced formation of heteromeric 
receptor complexes. Recent evidence suggests non-canonical BMP signalling may also occur 
via the activation of an integrin-linked kinase (ILK)/p38MAPK/ activating transcription factor-2 
(ATF-2) signalling pathway. The initiator of ILK remains unknown but could involve ligand-
induced or preformed heteromeric receptor complexes and/or ALK-independent receptor 
activation (dashed arrows). ALK, activin-like kinase (from Nickel et al., 2009). 
 
BMP signal transduction 
To summarize the so called “default” modus operandi of the BMP family - BMP 
ligands signalling is mediated via activation of intramembrane serine/threonine 
receptors kinase that either activate or repress intra-cellular SMAD proteins - 
homologues of both the Drosophila protein, mothers against decapentaplegic 
(MAD) and the Caenorhabditis elegans protein SMA -  that upon BMP mediated 
signal transduction translocate to the nucleus and either activate or repress 
BMP target genes (Attisano and Wrana, 1998; Derynck et al., 1996). Many 
studies, involving the use of diverse animal models and research strategies, 
have contributed to the state-of-the-art knowledge concerning the key players 
involved in TGF-β/BMP signal transduction (Moustakas and Heldin, 2009). In 
addition, both the BMP and TGF-β signalling pathways can also trigger SMAD 
independent signal transduction pathways that involve MAP kinase pathways 
(von Bubnoff and Cho, 2001). 
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SMAD mediated BMP signal transduction 
Canonical BMP signal transduction requires SMAD proteins (Attisano and 
Wrana, 1998; Derynck et al., 1996), which are highly conserved at their amino- 
and carboxyl-terminal regions (MH1 and MH2 to their homology to MAD 
proteins). These conserved domains are separated by a less conserved proline-
rich linker region (Hoodless et al., 1996; Kim et al., 1997). The Smad gene 
family can be subdivided into three sub-families: receptor-regulated, common-
mediator and inhibitory SMADs (Massagué et al., 2005). The receptor-regulated 
SMADs (R-SMADs) are composed of the cytoplasmic SMAD1, SMAD2, 
SMAD3, SMAD5, and SMAD8. SMAD 1, 5, and 8 are mostly substrates for the 
BMP receptors, while SMAD 2 and 3 are substrates for the TGF-β, activin, and 
Nodal receptors. The common-mediator (Co-Smad) SMAD4 heterodimerizes 
with the R-Smads and encodes a nuclear translocation signal. Once in the 
nucleus, the R-SMAD:SMAD4 complex associates with a variety of cofactors 
that regulate the transcriptional response. In contrast, SMAD6 and SMAD7 are 
inhibitory SMAD (I-SMAD or anti-SMAD) that interfere with SMAD-receptor or 
SMAD-SMAD interactions (Attisano and Wrana, 1998; Imamura et al., 1997; 
Massagué, 1998; Massagué et al., 2005; Moustakas and Heldin, 2009; Nakao 
et al., 1997). SMAD6 preferentially inhibits SMAD-dependent BMP signalling 
(Imamura et al., 1997) while TGF-β signalling can be inhibited by both SMAD6 
and SMAD7 (Imamura et al., 1997; Nakao et al., 1997). Particular TGF-β and 
BMP –specific SMAD complexes can induce the expression of the I-SMAD that 
will negatively regulate signalling strength and duration (Fig.8; Attisano and 
Wrana, 1998). 
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Non-Smad mediated BMP signal transduction 
Both BMP and TGF-β ligand  mediated signal transduction can be SMAD 
independent, whereby some of those downstream pathways regulate SMAD 
activation while others induce unrelated responses (Derynck and Zhang, 2003). 
BMP/TGFβ can activate several mitogen-activated protein kinases (MAPKs), 
including extracellular signal-regulated kinases (ERKs), c-Jun, N-terminal 
kinases (JNKs) and p38 kinases (Attisano and Wrana, 1998; Derynck and 
Zhang, 2003; Yu et al., 2002). Several different kinases involved in these non-
SMAD signal pathways have been identified and the alternative signal 
transduction map is becoming more complex (Miyazono et al., 2010; Moustakas 
and Heldin, 2009). A schematic representation of that alternative BMP/TGFβ 
signal transduction pathways is shown in Figure 9. Alternative activation of the 
TAK1/MEKK1 and Ras signal transduction pathway has been shown to play an 
important role during kidney development. In particular BMP7 induces collecting 
duct cells in a SMAD independent manner via activation of the p38 MAPK 
integrin-linked kinase (ILK)/p38 MAPK/activatin transcription factor- 2 (ATF-2) 
pathway (Hu et al., 2004; Leung-Hagesteijn et al., 2005). Moreover, it has been 
demonstrated Ras/MEK activation is necessary and sufficient for TGFβ 
mediated Erk1 activation (Yue et al., 1999). Concomitantly, it was further 
demonstrated that ERK phosphorylates ADAM-17 which responds to kidney 
mesangial cells in a mouse model for renal fibrosis (Bell and Gooz, 2010).  
 
36 
 
 
 
Fig. 9. TGF-β receptor signalling through SMAD independent pathways. Apart from 
proteins that interact with receptors and SMADs, other proteins (green) can associate with the 
type II or type I receptors and regulate TGF-β ligand signalling without an apparent direct effect 
on SMAD activation. In addition, the activated receptor complex activates non-SMAD signalling 
pathways, such as MAPK, PP2A/p70S6K, RhoA and TAK1/MEKK1. Only the best-characterized 
pathways are shown (from Derynck and Zhang, 2003). 
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Extracellular regulation of BMP ligand activity and availability 
In addition to regulation of BMP signal transduction, extracellular antagonists 
and agonists fine tune the interactions of ligands with their cognate receptors. 
The following sections will focus on extracellular modulators that are involved in 
metanephric kidney development.  
 
BMP extracellular antagonists 
BMP antagonists function by direct binding to BMP ligands, thus inhibiting their 
binding to their cognate receptors, which modulates BMP activity or defies 
boundaries of signalling (Hsu et al., 1998). Although several antagonists are 
expressed in the metanephric kidney from an early stage, only a few seem to 
play a role in nephrogenesis (Cain et al., 2008). 
Gremlin1 (Grem1) is a member of the DAN/Cerberus gene family (Hsu et al., 
1998). Gremlin1 was identified in Xenopus laevis embryos, due to its ability to 
induce a secondary axis, as a consequence of antagonising BMP signalling. 
That study also showed that Grem1 is expressed in the Xenopus pronephric 
kidneys, which provided the first hints of Grem1 potential roles in kidney 
development (Hsu et al., 1998). Grem1 expression is first detected in the mouse 
embryo around E8.5, in the intermediate mesoderm, somites, roof plate of the 
posterior neural tube fore- and hindlimb buds (Pearce et al., 1999). GREM1 was 
identified as a BMP antagonist required for its role in maintaining the SHH/FGF 
loop that controls limb distal outgrowth (Capdevila et al., 1999 ; Zuniga et al., 
1999). Genetic analysis of the GREM1-BMP antagonistic interactions revealed 
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that its morphoregulatory function in the epithelial-mesenchymal feedback 
signalling loops is required for the mouse limb bud development, renal 
branching morphogenesis and lung development (Michos et al., 2004). In 
particular, complete agenesis was observed in Grem1 deficient embryos. At an 
early stage, normal Wolffian ducts and ureteric buds form in Grem1 deficient 
mouse embryos. That Grem1 may also function postnatally was evidenced by a 
study in which rats were treated with streptozotocin to induce diabetic 
nephropathy in vivo (Wardle, 1975; Rossini et al., 1977). Such rats displayed 
high Grem1 levels in the renal cortex and abnormal Bmp2 induction (McMahon 
et al., 2000). This study also associated the GREM1 up-regulation with high 
glucose levels resulting from the diabetic nephropathy. Taken together these 
studies suggested that GREM1 is a potential endogenous antagonist of BMPs 
in diabetic glomerular context. Furthermore, clinical studies indicated that 
Grem1 might be a downstream mediator of TGF-β, suggesting a role for Grem1 
in epithelial-to-mesenchymal transition (EMT) as is observed in chronic allograft 
nephropathies. Such nephropathies are the most common cause of end-stage 
renal disease in kidney transplant patients (Carvajal et al., 2008). 
The BMP antagonist Noggin was first identified as a secreted protein that was 
able to dorsalize the Xenopus laevis ventral mesoderm, like Spemann’s 
organizer (Smith and Harland, 1992; Smith et al., 1993). NOGGIN binds several 
BMP ligands with different affinities, such as BMP2 and BMP4 with high and 
BMP7 with low affinity (Brunet et al., 1998; McMahon et al., 1998). Despite the 
fact that Noggin knock-out mice do not display any renal phenotypes, NOGGIN 
may play a role in nephrogenesis (McMahon et al., 1998). Indeed, ectopic 
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expression of Noggin in podocytes using the Nephrin promoter revealed a 
defect in mesangial cells (Miyazaki et al., 2006). This ectopic expression was 
sufficient to inhibit BMP signalling, which resulted in cyst formation and 
decreased mesangial cells population. Another important clue of a possible 
NOGGIN involvement in tissue homeostasis was obtained by analysing the 
regeneration process following ischemic acute renal failure (Villanueva et al., 
2006). Noggin expression was detected in the impaired kidney, in correlation to 
the local up-regulation of BMP7, which indicates that NOGGIN might be 
involved in tissue regeneration after acute renal failure. 
 
BMP extracellular agonists 
While BMP antagonists negatively modulate the BMP activity, other 
extracellular signals positively modulate BMP signalling (agonists) (Balemans 
and Van Hul, 2002). Several BMP agonists have been identified and some of 
them are likely required during metanephric kidney development.  
KCP, the mouse Kielin/chordin-like protein, was identified from an embryonic 
kidney cDNA library (Lin et al., 2005). In cultured cells it was shown that KCP 
enhances BMP7 expression and increases SMAD1 mediated BMP signal 
transduction. While KCP deficient mice do not display overt kidney phenotypes, 
their recovery from acute renal injury is impaired as a likely consequence of 
KCPs normal branching in enhancing BMP7 signal transduction (Lin et al., 
2005). Recent additional insights into the KCP functions have been obtained. 
While KCP enhances BMP activity, it inhibits TGF-β though SMAD2/3 signal 
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transduction. Therefore KCP may modulate TGF-β superfamily signalling during 
kidney homeostasis by inhibiting TGF-β and enhancing BMP signalling during 
acute renal injury (Lin et al., 2006). 
CV2 (CROSSVEINLESS2 – also known as BMPER) was identified in 
Drosophila because of its properties to enhance BMP signalling during the 
formation of the wing cross veins (Conley et al., 2000). The protein encoded by 
the Cv2 gene, not only co-localizes with but also, potentiates Gbb (Glass 
bottom boat), a Drosophila BMP orthologue (Ballard et al.; Conley et al., 2000).  
Several studies with Cv2 orthologue genes in vertebrate embryos established 
that CV2 enhances in particular BMP7 signalling (Ikeya et al., 2006). Cv2 
deficient mice show skeletal and eye phenotypes, along with kidney 
malformations. Cv2 expression in the metanephric mesenchyme and 
developing nephrons correlates with the hypoplastic kidney phenotypes and 
reduced nephron numbers. The generation of compound mutant mice and 
embryos revealed that inactivation of Kcp in a Cv2 mouse aggravates the acute 
kidney deficiencies (Ikeya et al., 2006).  
Considering the current state of knowledge in BMP signalling during 
metanephric kidney development several questions remain open. BMP 
signalling can be regulated by antagonists, agonists and receptor availability but 
only a thorough investigation into how BMP ligands interact with one another 
and how BMP signals are transduced will provide a better understanding of their 
role during kidney organogenesis. 
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V. AIM OF THE THESIS 
 
The current state of research 
Genetic analysis has established a critical role for the extra-cellular BMP 
antagonist GREMLIN1 in establishment of epithelial-mesenchymal (E-M) 
feedback signalling during limb and kidney organogenesis (Michos et al., 2004; 
Zuniga et al., 1999; Zuniga et al., 2004). Inactivation of Grem1 in mouse 
embryos by homologous recombination causes severe defects of distal limb 
bud development and complete renal agenesis (Michos et al., 2004). Molecular 
and embryological studies revealed an absolute requirement for Grem1-
mediated antagonism (i.e. inhibition) of BMP activity to enable progression of 
limb bud and metanephric kidney organogenesis. In particular, Grem1-mediated 
E-M feedback signalling is required to initiate the transition from static to 
dynamically propagated signalling centres as organogenesis progresses 
(Michos et al., 2004) and for temporal coordination of the cellular response to 
morphogenetic signals (Panman et al., 2006). Grem1 acts upstream of GDNF-
RET-mediated branching morphogenesis in the developing metanephric kidney 
and upstream of SHH-controlled patterning in the limb bud. Therefore, further 
analysis of the BMP-Grem1 antagonistic interactions will provide general 
insights into how the dynamic growth and patterning phase, characteristic of the 
development of many organs, is initiated/ set-up and co-ordinately controlled. 
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Objectives 
I intended to study the epithelial-mesenchymal (e-m) feedback signalling 
controlling kidney organogenesis by performing a genetic analysis of BMP-
Gremlin1 antagonistic interactions.  
In performing these studies I took into consideration the known molecular 
interactions underlying limb bud and metanephric kidney organogenesis. 
The first aim of this Ph.D. project was to identify the BMP ligand(s) antagonised 
by Grem1 during limb and kidney organogenesis. 
The second aim was to investigate whether and how the local BMP antagonism 
controls initiation and progression of ureter branching morphogenesis. 
The third aim was to genetically assess the contributions of BMP4 and BMP7 to 
the e-m feedback signalling interactions during kidney and limb bud 
development. 
 
Detailed Description 
This project initially focused on the following major questions: 
1. Which are the relevant BMP ligand(s) antagonised by Grem1 during limb 
and kidney organogenesis? BMP4 is an obvious candidate in the 
developing kidney, as others have provided some evidence that this 
BMP ligand is involved in early metanephric organogenesis. This issue 
was genetically addressed by generating double mutant embryos (or 
mice) lacking both Grem and Bmp4. Of particular interest was to define 
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and study if inactivation of one and/or both alleles of Bmp4 in addition to 
Gremlin improves or worsens kidney and/or limb organogenesis. Not 
only the phenotypes, but also the disrupted or restored underlying 
molecular cascades were to be analysed as the group has done 
previously for other double compound mutant embryos (te Welscher et 
al., 2002). The conditional Bmp4 allele allows the inactivation of this 
gene in a tissue and stage-specific manner to analyse both its spatial 
and temporal requirement in single and double mutant mouse embryos. 
All the required Cre transgenic mouse strains for performing this genetic 
analysis were available. As well as a conditional Bmp4 allele, a Bmp7 
loss-of-function was available to assess its role during kidney 
development in combination with Gremlin1. 
 
2. Does local BMP antagonism control branching morphogenesis? In 
addition to sophisticated mouse genetics, the available culture system for 
mouse embryonic kidneys is a tool to locally perturb BMP-antagonist 
interactions in two ways:  
Either by recombination of wild-type with mutant tissue following 
separation of the epithelial and mesenchymal compartments or by 
engraftment of small cell aggregates expressing either specific BMPs or 
Grem1 (Zuniga et al., 1999). Moreover, the invading and branching 
ureter epithelia can be made to express GFP by crossing the Hoxb7-
GFP transgene into the desired genetic makeups. 
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3. Are Grem1 and Bmp7 interactions essential for kidney organogenesis?  
Grem1/Bmp7 genetic studies were elaborated to investigate the 
underlying molecular interactions. The question is whether Bmp7 
inactivation can improve or worsens the Grem1 phenotype. Moreover, 
Bmp4/Bmp7 compound mutant mouse/embryos can generate insight into 
the role of those BMP ligands during metanephric kidney development.  
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VI. MATERIAL AND METHODS 
 
Genetic analysis of the GREM1–BMP4 interactions (studies performed 
together with Odyssé Michos and Jean-Denis Bénazet) 
All animal experiments were performed in accordance with Swiss law and were 
approved by the regional veterinary authorities. 
 
Grem1 and Bmp4 mouse strains and research approach 
The genetic analysis was performed using different mouse strains carrying 
either conditional or constitutive loss-of-function alleles. Grem1 is located on 
mouse chromosome 2, while Bmp4 is located on mouse chromosome 14. Some 
studies were executed using a Hoxb7 transgene inserted into mouse 
chromosome 11. 
The Grem1–Bmp4 genetic analysis was performed with mice carrying the 
Grem1∆ null allele (Michos et al., 2004). Grem1∆ mice were crossed with mice 
carrying the Bmp4∆ allele. The Bmp4 gene was inactivated in the germline by 
inter-crossing the floxed Bmp4loxP-lacZ allele (Kulessa and Hogan, 2002) with the 
Cre deleter mouse strain (Schwenk et al., 1995). The resulting Bmp4∆–lacZ allele 
was used to generate compound mutant mice for analysis in a mixed 
129/C57BL6 background. Compound mutants carrying the Hoxb7-GFP 
transgene to mark the ureteric epithelium (Srinivas et al., 1999) were also used 
for analysis. The primer pairs used for genotyping all wild-type and mutant 
alleles are listed in Table 1. Embryonic tissue, preferentially the head or extra-
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embryonic membranes, was used for genotyping embryos and tail tip or ear 
punch biopsies, were used to genotype mice at weaning age.  
 
Bmp4 spatiotemporal conditional inactivation 
A Tamoxifen (TM)-inducible form of the P1 phage-derived integrase Cre was 
used to recombine genes at specific time points during embryonic development 
using loxP target sites. Hayashy and MacMahon generated the Cre-ERTM 
transgenic mouse line by fusing Cre and a mutated form of the ligand binding 
domain of the estrogen receptor (ER) that renders Cre activity tamoxifen (TM) 
inducible (Hayashi and McMahon, 2002). Wide spread expression in embryos 
and mice was obtained by putting Cre-ERTM under control of the 
cytomegalovirus immediate-early enhancer and the chicken β-actin 
promoter/enhancer (CAGG) (Niwa et al., 1991). Females carrying one Bmp4∆ 
allele were crossed with Cre-ERTM males to generate Bmp4∆/+ ; Cre-ERTM/+ 
males. Females homozygous for the conditional Bmp4loxP-lacZ were crossed with 
these Bmp4∆/+ ; Cre-ERTM/+ males. Pregnant females received an intraperitoneal 
(IP) injection with tamoxifen and/or embryos were collected and kidney 
rudiments cultured in the presence of 4OH-tamoxifen. 
 
Reagents: 
Tamoxifen preparation for IP injection: 
A stock solution of 100 mg/ml TM (Sigma) in ethanol (pure grade) was diluted in 
corn oil (Sigma) to achieve a 20 mg/ml final concentration. 40 mg/ml of 
progesterone (Sigma) was added to attenuate the abortive effects of TM. An 
emulsion was obtained after 30 minutes of sonication and 150 μl of TM-
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progesterone solution was injected intraperitoneally into pregnant females (3 
mg TM/mouse) at the embryonic days indicated (E8.75-E9.5). 
 
4OH-tamoxigen preparation for kidney cultures: 
A stock solution of 100 mg/ml 4OH-TM (Sigma) was prepared in ethanol. The 
stock solution was then diluted to 100 µg/ml and 100ng/ml and stored in 
aliquots at 20ºC.  
 
Genetic analysis of GREM1–BMP7 interactions 
Both Grem1 and Bmp7 are located on the mouse chromosome 2, therefore the 
following genetic approach was required. Mice carrying the Grem1∆ null allele 
(Michos et al., 2004) were crossed with Bmp7∆ null mice (Karsenty et al., 1996) 
and their offspring was crossed with wild-type 129 mice. The resulting F2 
offspring were screened for mice carrying both mutations in cis due to germline 
recombination. Grem1∆/∆; Bmp7 ∆/∆ double homozygous embryos were 
generated by inter-crossing males carrying both mutations in cis with females 
carrying both mutations either in cis and trans. To generate single mutant 
Grem1∆/∆ or Bmp7∆/∆ embryos/mice carrying the respective ∆ null alleles were 
inter-crossed. The same inter-crosses were used to obtain newborn mice for 
analysis. The genetic background influence was assessed and the results are in 
Table 1. The primers listed in Table 2 were used for genotyping.
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Table 1 – Assessment of the background effect in the Grem1; Bmp7 analysis. 
Genotypes    2 kidneys     1 Kidney          0 kidneys      Total 
 
Grem1 ; Bmp7 x Grem1 ; Bmp7  
Grem1∆/∆        0  1   (10%)       9   (90%)        10  
Grem1∆/∆; Bmp7∆/+ 
 
 
Grem1 x Grem1 ; Bmp7  
Grem1∆/∆ 
     0  
       
 
 
     0 
   1   (2,4%) 
 
 
 
 0 
    14   (93%) 
       
 
 
      7  (100%) 
       15 
         
 
 
         7 
Grem1∆/∆ ; Bmp7∆/+      0 1   (17%)       5  (83%)          6 
                                                                                                                    
 
Table 2 – Primers used for PCR genotyping of mice and embryos. 
Gene Forward Primer Reverse Primer Allele 
Grem1 
ATGAATCGCACCGCATACACTG 
GGCACATGGCTGAATATCGACGG 
TCCAAGTCGATGGATATGCAACG 
AAGCGCCTCCCCTACCCGGTA 
Wt 
null 
Bmp4 
GTGTGTGTAGGGTGTGAGGGAGAAA 
ATGAATCGCACCGCATACACTG 
CCCGGTCTCAGGTATCAAACTAGCA 
ATGAATCGCACCGCATACACTG 
Wt/f 
null 
Bmp7 
TTGTGCTGTGTAGACTGGGTG 
TGTTCTCCTCTTCCTCATCTCC 
TTTGTAGGAGTGGTAGGGTGC 
ACCCTTTCCAAATCCTCAGC 
Wt 
null 
Hoxb7 AGCGCGATCACATGGTCCTG ACGATCCTGAGACTTCCACACT tg 
Cre GCCTGCATTACCGGTCGATGCAACGA GTGGCAGATGGCGCGGCA ACACCA TT tg 
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Molecular and morphological analysis of embryos and organs 
Embryos were accurately staged by determining their somite numbers. After 
embryonic day 12, the somite numbers were no longer considered, unless there 
was an obvious developmental delay. The kidney rudiments were dissected 
with approximately 2/3 of the Wolffian duct. Whole-mount and section RNA in 
situ hybridisation, immunohistochemistry (IHC) and detection of β-galactosidase 
activity were performed.  
 
Paraffin embedding and histological sections of embryos and kidney rudiments 
were performed as follows: 
 
Paraffin embedding 
After embryo collection or organ dissection, samples were fixed overnight (O/N) 
with 4%PFA in PBS at 4°C. 
Embryos were gradually dehydrated using a serial dilution of EtOH in dH2O. 
The ethanol serial washes were done either on ice or in the 4ºC room:  
PBS 2 X 10 minutes 
30% EtOH  3 X 20 minutes 
50% EtOH  3 X 20 minutes 
70% EtOH  3 X 20 minutes 
Samples can be stored for a long time in 70% EtOH at 4°C before sectioning. 
Next day, the samples in 70% EtOH were allowed to warm up to room 
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temperature (RT) and the protocol proceeded with several washes and 
incubation periods towards paraffin wax embedding: 
100% EtOH 3 X 20 minutes at RT 
100% xylene 3 X 15 minutes at RT 
Incubation in paraffin wax: xylene (1:1) 30 minutes at 60°C 
Incubation in paraffin wax 3 X 60 minutes, 60°C 
Embryos were transferred to embedding molds with fresh paraffin wax. The 
paraffin was kept warm on a heating plate to correctly orientate the samples. 
Paraffin was then allowed to become hard O/N, RT. The paraffin blocks were 
kept at 4ºC before sectioning. 
 
Coating slides with 3-triethoxysilylpropylamine (TESPA) 
Pre-cleaned glass slides of high enough quality for both in situ and 
immunohistochemical techniques were used. For in situ hybridization, the slides 
were treated with diethyl pyrocarbonate (DEPC) to destroy RNases. The slides 
were coated with TESPA (Sigma-Aldrich) for tight adherence of sections, which 
ensured that they did not detach during subsequent hybridisation and extensive 
washing. 
Slides were coated using histology glass tanks and slides supports as follows 
(washes at RT): 
1 minute in 2N HCl 
1 minute in milliQ water 
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1 minute in 100% acetone (pure) 
1 minute in TESPA/acetone (1:1) 
1 minute 100% acetone 
1 minute 95%EtOH 
1 minute 50% EtOH 
1 minute 30% EtOH 
3 X 1 minute in milliQ water  
The slides were dried O/N in a 42ºC oven and stored at 4ºC in boxes. 
 
Histological sectioning of paraffin-embedded samples  
Sections were prepared at the Department of Histology, Anatomy Institute of the 
University of Basel. For histological analysis, 7-10 µm sections were prepared 
from the paraffin-embedded samples fixed in 4% PFA. Dewaxed sections were 
either stained with haematoxylin and eosin or periodic acid schiff (PAS) to 
reveal the brush border (microvilli) of the distal and proximal tubules. The 
sections that were prepared for in situ hybridization or IHC were stored at 4ºC. 
 
Whole-mount in situ hybridization - modified from David Wilkson’s protocol 
(Wilkinson, 1992) 
Embryos and dissected kidney rudiments were collected in PBS and fixed O/N 
in 4% paraformaldehyde (PFA Sigma in PBS) and dehydrated using an 
increasing methanol series and stored in methanol at -20ºC. The dehydration 
and all the following procedures, except the proteinase K treatment, were 
performed using a rocking platform shaker. Early embryos or kidney rudiments 
were stored and handled in 2 ml Eppendorf tubes or multi-well plates. Following 
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their genotyping and matching of developmental stages, embryos were 
rehydrated using a reverse methanol into PBT series (PBT: PBS with 0.1% 
Tween 20). Embryos/organs were bleached for 15 minutes using H2O2 (Sigma) 
in PBT and washed 3 X 5 minutes in PBT. Embryos were digested using 10 
µg/ml Proteinase K (mesenchymal treatment) in PBT according to the following 
Table: 
Developmental Stage Incubation Time 
38-40 somites (E10.75) 5 minutes 
41-45 somites (E11.0) 6-7 minutes 
46-50 somites (E11.5) 8-10  minutes 
51-55 somites (E11.75) 11 minutes 
E12.5 12 minutes 
E13.5 – E15.5 15 minutes 
 
E10.75 – E11.5 kidneys cultured for 48 hours were digested with proteinase K 
for 6 minutes only. Proteinase K was inhibited by rinsing the slides for 5 min in 
glycine/PBT (2 mg/ml) solution. The samples were then rinsed twice in PBT and 
fixed 20 minutes in 4% PFA, PBS, 0.2% glutaraldehyde (Sigma). After rinsing 
twice for 5 minutes in PBT, embryos were pre-hybridized 3 hours at 65ºC with 2 
ml of hybridization buffer. After this pre-hybridization, the solution was replaced 
by hybridization solution (prewarmed to 70ºC) containing 10 µl/ml of 
digoxigenin-labelled RNA probe. The hybridization was incubated O/N at 70ºC 
in an oven with a rotor. 
After O/N incubation, embryos were changed into 2X SSC in a graded manner 
by replacing the hybridization probe solution with hybridization buffer and a 
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graded 2X SSC series at 70ºC. After incubating twice for 30 minutes with 2X 
SSC/0.1% CHAPS at 70ºC, an RNAse A (20 mg/ml in 2X SSC , 0.1% CHAPS) 
digestion was performed for 45 minutes at 37ºC  to remove non-specific single 
stranded RNA molecules. Samples were washed twice for 10 minutes with 100 
mM maleic acid, 150 mM NaCl pH 7.5 at room temperature and then twice at 
70ºC  with the same solution. After two final washes in PBS and 5 minutes in 
PBT at room temperature, samples were blocked for 2-3 hours in 10% sheep 
serum,1% bovine serum albumin (BSA)  in PBT before adding the anti-
digoxigenin antibody (Fab fragments Roche). The antibody solution was 
prepared by heat inactivating 3 mg/ml of embryo powder in PBT for 30 minutes 
at 70ºC and quenching on ice. 1 µl/ml anti-digoxigenin antibody (Fab fragments 
Roche), 10 mg/ml BSA and 10% inactivated sheep serum were added to the 
embryo powder in PBT solution and it was kept rocking at 4ºC for 2-3 hours to 
pre-absorb the antibody. The antibody solution was then centrifuged at 10.000 
rotations per minute (RPM) for 10 minutes and the supernatant diluted 1:1 with 
blocking solution. The blocking solution was then replaced by the antibody 
solution and the samples were incubated overnight at 4ºC. 
Next day, embryos were washed 5 X 45 minutes with PBT, 0.1% BSA, twice 30 
minutes with PBT and 3 X 10 minutes in NTMT. The signal was then revealed 
by incubating the samples in the dark with BM purple solution (Roche) at room 
temperature. The coloration process was visually monitored and stopped in 
NTMT followed by 3 washes with PBT. For long-term stabilization of the 
staining, the samples were stored in 4% PFA in PBS at 4ºC. 
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Reagents: 
Hybridization buffer: 
50% formamide (deionized, extra pure) 
5X SSC pH 4.5 (from a 20x stock: 3 M NaCl , 0.3 M tri-sodium citrate 
dehydrate) 
2X Blocking Reagent (Roche) 
0.1% Tween 20 
0.5% CHAPS 
5 mM EDTA 50 
50 µg/ml yeast tRNA 
50 µg/ml heparin 
 
NTMT: 
100 mM NaCl 
100 mM Tris HCl pH 9.5 
50 mM MgCl2 
0.1% Tween 20 
 
β-Galactosidase staining of embryos and kidney rudiments 
Samples were isolated, staged on a petri dish and transferred into 2 ml Eppendorf 
tubes containing ice-cold PBS. All samples must be kept ice-cold to preserve β-Gal 
activity. PBS was replaced by fixative solution and samples were fixed during 25 
minutes at 4ºC on a rocking platform. Samples were rinsed 3 times for 5 minutes in 
PBS at RT. Solutions X, K3 and K4 were brought to RT away from the light during the 
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samples PBS washes. PBS was then replaced by staining solution and samples were 
stained at 37ºC in a rotating oven (protected from light). The staining reaction 
requires from several hours to overnight periods. The reaction was stopped by RT 
PBS washes and samples stored in 4% PFA in PBS. If stained samples were to be 
used for in situ hybridization, samples had to be fixed in 4% PFA in PBS for at least 4 
hours at 4ºC and dehydrated with the regular MetOH/PBT series. 
 
Reagents: 
Fixing solution 
37% Formaldehyde  1.35 ml 
25% Gluteraldehyde    400 µl 
10%NP40 (Igepal)      100 µl 
1% Sodium deoxycholate  500 µl 
Add PBD to 50 ml final volume 
 
Staining solution for embryos up to E12.5 
Solution X (X-gal 40 mg/ml)   625 µl 
*Solution K3 (500 mM K3Fe(CN6))      25 µl 
*Solution K4 (500 mM K4Fe(CN6))      25 µl 
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10% NP40       50 µl 
MgCl2 1M       20 µl 
Add PBS to 50 ml 
 
Staining solution for embryos E13.5 or older 
Solution X (X-gal 40 mg/ml)   625 µl 
*Solution K3 (500 mM K3Fe(CN6))      25 µl 
*Solution K4 (500 mM K4Fe(CN6))      25 µl 
10% NP40       50 µl 
MgCl2 1M       20 µl 
1% Sodium deoxycholate        500 µl 
Add PBS to 50 ml 
*For genes that are highly expressed used 10x as much. 
 
Stock solutions 
X-Gal dissolved in dimethyl formamide at 40 mg/ml, store at -20ºC 
500 mM potassium ferricyanide (K3) in PBS (3.3 g in 20 ml PBS, store in 1 ml 
aliquots at -20ºC and do not re-freeze). 
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500 mM potassium ferricyanide (K4) in PBS (4.2 g in 20 ml PBS, store in 1 ml 
aliquots at -20ºC and do not re-freeze).  
Immunohistochemistry (IHC) assays 
Samples were isolated, staged and transferred into 10 ml glass vials containing 
cold PBS. The solution was then replaced by freshly made 4% PFA in PBS and 
the vials were put at 4ºC on a rocking platform for overnight fixation. After 
fixation, samples were processed according to the previously described 
procedures for “Paraffin Embedding”. 
 
PODOCALYXIN and CYTOKERATIN Double Immunostaining 
Immunostaining for PODOCALYXIN reveals the C-shaped aggregates of 
podocytes of the renal glomeruli (Schmidt-Ott et al., 2006). In addition, 
CYTOKERATIN detection reveals the ureteric bud branches and collecting 
system epithelia. The simultaneous detection of these markers was a good tool 
to assess the kidneys integrity. 
Dewaxed sections slides were boiled at 120ºC for 90 seconds in 10 mM Sodium 
Citrate (C6H5Na3O7*2H20 – Merck) for antigen retrieval. Slides were 
immediately removed from the pressure cooker and let to cool off at room 
temperature for 30 minutes. After being rinsed in tap water and washed twice 
for 5 minutes with 0.1% Triton-10 in PBS, the sections were pre-blocked one 
hour with PBS, 0.1% Triton-10, 10% donkey serum, 0,2% BSA at RT. After 
washing sections three times with PBS, 0.1% Triton-10, the sections were 
incubated with the primary antibody solution overnight at 4ºC.  
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Primary antibody solution in PBS, 0.1% Triton-10: 
Polyclonal goat anti-mouse Podocalyxin (R&D Systems) 1:50  
Monoclonal mouse anti-pan Cytokeratin (Sigma) 1:50 
 
The next day, the antibody solution was removed and the sections were 
washed with PBS, 0.1% Triton-10 for three hours (6 X 30 minutes washes). The 
antibody was recovered because it can be re-used once.  The PBS, 0.1% 
Triton-10 was replaced by the secondary antibody and the sections were 
incubated for one hour at RT in the dark.  
 
Secondary antibody solution in PBS, 0.1% Triton-10: 
Cy2 (green) donkey anti-mouse IgG (Amersham) 1:200 
Cy3 (red) donkey anti-goat IgG (Amersham) 1:100 
 
The sections were washed with PBS, 0.1% Triton-10 for two hours (4 X 30 
minutes). A counterstain with Hoechst 33258 (5 mg/ml) was performed for 5 
minutes to reveal the nuclei followed by a PBS wash for 5 minutes more. The 
slides were then mounted with Mowiol (Calbiochem). 
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Reagents: 
Mowiol preparation 
1. Weigh 6 g glycerol (water-free) into a 50 ml Falcon Tube  
2. Add 2.4 g of Mowiol 4-88 (Calbiochem)3. Mix very well 
4. Add 6 ml of H2O 
5. Mix for 2 hours at RT 
6. Add 12 ml of 0.2 M Tris HCl pH 8.5 
7. Incubate solution at 53ºC until everything is completely in solution, stir 
occasionally 
8. Spin at 4.000 to 5.000 RPM for 20 minutes at RT 
9. Aliquot clear supernatant into glass vials and store at -20ºC until used 
10. Use a defrosted aliquot for mounting, do not refreeze 
 
Kidney rudiment cultures 
 
Kidney primordia culture 
Kidney primordia were isolated from somite-staged wild-type and mutant 
embryos. Kidney rudiments were cultured in DMEM (Dulbecco’s Modified Eagle 
Medium) + GlutamaxTM-I (Gibco) supplemented with 10% foetal bovine serum 
(Invitrogen) and 0.5% penicillin-streptomycin (Invitrogen) on Nucleopore filters 
(0.1 µm pore size, Corning) as  previously described (Lin et al., 2001) with the 
following modifications. Experiments were performed using E10.75-11.25 (38-
44 somites) embryos instead of the classic T-shape stages (E11.5, 48-50 
somites). It is important to realise that it is not possible to efficiently rescue 
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kidney primordia from Grem1-deficient embryos older than E11.25. A piece of 
Gelfoam (Pfizer) was soaked in medium and the Nucleopore filter with the 
kidney primordia was placed on top in a 6-well plate and incubated in a 
humidified atmosphere at 37°C with 5% CO2. Mouse recombinant GREM1 
(R&D Systems – catalogue number 956-GR) was added to the culture medium 
at 2-5 µg/ml and changed every 48 hours. Noggin-conditioned medium was 
produced using the B3-CHO cell line (Smith et al., 1993) and used at a dilution 
of 1:4. Rat recombinant GDNF (R&D Systems - catalogue number 512-GF) was 
used at 100 ng/ml final concentration. After culture, the kidney primordia were 
fixed in 4% paraformaldehyde (PFA) and processed for molecular analysis.  
 
Semi-quantitative RT-PCR analysis  
Kidney rudiments were collected either directly or after 48 hours in culture into 
RNA-later (Ambion). RNA was isolated from four kidney rudiments per genotype 
using the RNeasy kit (Qiagen) and reverse transcribed using Superscript III 
(Invitrogen). The cDNA contents of all samples were normalised for their β-actin 
(Actb – Mouse Genome Informatics) transcripts (primer sequences: forward 5’-
ACACTGTGCCCATCTACGAGG-3’; reverse 5’ CATGGATGCCACAGGATTCC-
3’).  
The relative levels of Gdnf and Grem1 transcripts were determined using 
established primers [Gdnf (Towers et al., 1998); Grem1(Zuniga et al., 2004)] 
located in two different exons to avoid potential amplification of genomic DNA: 
- Gdnf forward primer: 5’- CGCTGACCAGTGACTCCAATATGC -3’ 
- Gdnf reverse primer: 5’- ACATTGTCTCGGCCGATTCACAGG -3’ 
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The PCR products were separated on 1.8% agarose gels and visualised by 
ethidium bromide staining. Digital images were acquired to determine the 
relative expression levels using the LI-COR Odyssey Imaging Software (version 
2.0). Three completely independent series of experiments were performed to 
assess Gdnf expression. 
 
Affymetrix gene chip microarray analysis 
To investigate which genes were involved in the restoration of the Grem1∆/∆ 
kidney phenotype, a microarray analysis experiment was designed to allow us 
to compare the wild-type, Grem1∆/∆ and Grem1∆/∆; Bmp4∆/+ kidney rudiments. A 
high resolution expression analysis, comprising more than 750,000 unique 25-
mer oligonucleotides constituting more than 28,000 gene-level probe sets, was 
performed using GeneChip® Mouse Gene 1.0 ST Arrays (Affymetrix). 
 
Kidney rudiments collection, gender determination and RNA isolation 
Kidney rudiments were collected from E11.25-11.5 (47-48 somites) embryos 
and put into RNA-later (Ambion). Embryos heads were isolated and extracted 
genomic DNA used to determine the genotype and gender of the embryos 
(heads were split in half for posterior independent analysis if required).  Sex 
determination was performed using the Sex-determining Region Y (Sry), which 
is a sex-determining gene on the Y chromosome in the therians (placental 
mammals and marsupials (Wallis et al., 2008) and Myogenin (Myog) was used 
as an internal control as described in (McClive and Sinclair, 2001). Triplicates of 
each genotype of interest (wild-type, Grem1∆/∆ and Grem1∆/∆; Bmp4∆/+) were 
then processed for analysis.  
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The primers used to determine the embryo’s gender were: 
- Sry forward primer: 5’- TCATGAGACTGCCAACCACAG -3’ 
- Sry reverse primer: 5’- CATGACCACCACCACCACCAA -3’ 
- Myog forward primer: 5’- TTACGTCCATCGTGGACAGC -3’ 
- Myog reverse primer: 5’- TGGGCTGGGTGTTAGTCTTA -3’ 
 
RNA isolation and analysis 
Male kidney rudiments stored in RNA-later were processed for RNA extraction. 
RNA isolation was performed using the Qiagen Mini Kit. RNA was extracted 
using RNeasy Mini Spin Columns (Qiagen) using the Qiagen recommended 
protocol. RNA fragment length degradation was assessed using an Agilent 
Bioanalyzer. An average of 3µg of total RNA was extracted. 5µl RNA samples 
with a concentration of 60 ng/ µl of RNA were given to the Friedrich Miescher 
Institute Functional Genomics department for microarray hybridization, posterior 
data mining and analysis. 
 
Affymetrix Genechip® hybridization and scanning 
The regular Affymetrix “GeneChip® Whole Transcript (WT) Sense Target 
Labelling Assay” was followed using 240 ng of the kidneys rudiments RNA from 
the different genotypes. Briefly, double-stranded cDNA was synthesized with 
random hexamers tagged with a T7 promoter sequence. The double-stranded 
cDNA was subsequently used as a template and amplified by T7 RNA 
polymerase producing many copies of antisense cRNA. In the second cycle of 
cDNA synthesis, random hexamers were used to prime reverse transcription of 
the cRNA from the first cycle to produce single-stranded DNA in the sense 
63 
 
 
orientation. The synthesized cRNA was used for hybridization to a single array. 
One Affymetrix Mouse Gene 1.0 ST Array was used per genotype (one kidney 
rudiments pair per genotype). Chips were hybridized for 17 hours at 45ºC using 
a GeneChip® Fluidics Station 450 and GeneChip®s were scanned with the  
GeneChip®  Scanner 3000. 
 
Genedata Expressionist Microarray data mining and Ingenuity® (Ingenuity 
Systems Inc.) pathway analysis 
Genedata Expressionist® was used and different statistical analysis tools were 
applied to generate reliable and reproducible results. After verifying the 
expression values per chip/experiment, an N-Way ANOVA was applied to the 
dataset. To reduce the probability of analysing hits, GeneChip® probes that 
hybridized with the cRNAs) that were due to biological variability and 
experimental imprecision, a P-VALUE p<0.05 was defined (it indicates a 
statistical significance over 95%). Once the primary data was filtered the 
analysis proceeded comparing the statistically validated targets from the 
different genotypes samples. “Side-by-side” comparisons were done between 
pairs of different genotypes. After performing the Genedata Expressionist® data 
mining, the list of hybridized probes (hits) was used with Ingenuity®. Pairwise 
comparisons were made as follows: wild-type versus Grem1∆/∆, Grem1∆/∆; 
Bmp4∆/+ versus Grem1∆/∆ and Grem1∆/∆; Bmp4∆/+ versus wild-type. The “Top 
Networks” and “Top Bio Functions” were assessed and based on that analysis a 
new putative network of genes was designed and used for genetic and 
molecular analysis.   
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VII. REDUCTION OF BMP4 ACTIVITY BY GREMLIN1 ENABLES 
URETERIC BUD OUTGROWTH AND GDNF/WNT11 FEEDBACK 
SIGNALING DURING KIDNEY BRANCHING MORPHOGENESIS 
PUBLICATION: 
Odyssé Michos*, Alexandre Gonçalves*, Javier Lopez-Rios, Eva Tiecke, 
Florence Naillat, Konstantin Beier, Antonella Galli, Seppo Vainio and Rolf Zeller. 
Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth 
and GDNF/WNT11 feedback signalling during kidney branching 
morphogenesis. * These authors contributed equally to this work. Development 
134, 2397-2405 (2007).  
 
Summary 
Antagonists act to restrict and negatively modulate the activity of secreted 
signals during progression of embryogenesis. In mouse embryos lacking the 
extra-cellular BMP antagonist Gremlin1 (Grem1), metanephric development is 
disrupted at the stage of initiating ureteric bud outgrowth. Treatment of mutant 
kidney rudiments in culture with recombinant Gremlin1 protein induces 
additional epithelial buds and restores outgrowth and branching. All epithelial 
buds express Wnt11, and Gdnf is significantly upregulated in the surrounding 
mesenchyme, indicating that epithelial-mesenchymal (e-m) feedback signalling 
is restored. In the wild type, Bmp4 is expressed by the mesenchyme enveloping 
the Wolffian duct and ureteric bud and Grem1 is upregulated in the 
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mesenchyme around the nascent ureteric bud prior to initiation of its outgrowth. 
In agreement, BMP activity is reduced locally as revealed by lower levels of 
nuclear pSMAD protein in the mesenchyme. By contrast, in Grem1-deficient 
kidney rudiments, pSMAD proteins are detected in many cell nuclei in the 
metanephric mesenchyme, indicative of excessive BMP signal transduction. 
Indeed, genetic lowering of BMP4 levels in Grem1-deficient mouse embryos 
completely restores ureteric bud outgrowth and branching morphogenesis. The 
reduction of BMP4 levels in Grem1 mutant embryos enables normal progression 
of renal development and restores adult kidney morphology and functions. This 
study establishes that initiation of metanephric kidney development requires the 
reduction of BMP4 activity by the antagonist Gremlin 1 in the mesenchyme, 
which in turn enables ureteric bud outgrowth and establishment of 
autoregulatory GDNF/WNT11 feedback signalling.  
 
Introduction 
Mammalian kidney organogenesis is regulated by reciprocal epithelial-
mesenchymal (e-m) signalling interactions that involve inductive signalling 
between ureteric bud epithelium and metanephric mesenchyme (Saxen, 1987; 
Yu et al., 2004). In mouse embryos, the ureteric bud forms around embryonic 
day (E) 10.5 as an epithelial swelling in the caudal-most part of the Wolffian 
duct. Development of the definitive kidney is initiated when the ureteric bud 
elongates to invade and induce the metanephric mesenchyme. In turn, the 
induced metanephric mesenchyme produces signals that initiate nephrogenesis. 
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During ureteric bud outgrowth, the epithelial tip region thickens to form an 
ampulla just prior to appearance of the first epithelial branch (Shakya et al., 
2005). In addition, this process induces condensation of the metanephric 
mesenchyme, which is the first morphological sign of nephrogenesis (Saxen, 
1987). Many of the human congenital anomalies of the kidney and urinary tract 
(CAKUT) are caused by defects in these early inductive events, but their 
aetiology remains poorly understood (Batourina et al., 2002; Pope et al., 1999).  
During the last decade, significant parts of the molecular networks and e-m 
feedback signalling interactions that regulate mammalian kidney organogenesis 
have been identified (Costantini and Shakya, 2006; Vainio and Lin, 2002). It is 
established that ureteric bud formation and the induction of its branching require 
GDNF (glial cell line derived neurotrophic factor), a secreted growth factor that is 
expressed by the metanephric mesenchyme. The GDNF ligand interacts with its 
cognate receptor RET (ret proto-oncogene), which is first expressed by the 
Wolffian duct and then by the ureteric epithelial tips as branching 
morphogenesis progresses (Schuchardt et al., 1996). The current view is that 
establishment of signalling between GDNF, RET and its co-receptor GFRα1 
(glial cell line derived neurotrophic factor family receptor α1) is essential for 
ureteric bud formation and initiation of outgrowth and branching (Costantini and 
Shakya, 2006). As the rostral part of the Wolffian duct initially expresses Ret, it 
is competent to form supernumerary buds and branches upon exposure to 
GDNF (Shakya et al., 2005). Therefore, a mechanism must exist that restricts 
ureteric bud formation to the caudal-most part of the Wolffian duct. Indeed, 
supernumerary epithelial buds form in mouse embryos lacking either SLIT2 or 
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ROBO2 functions, the SPRY1 intra-cellular antagonist or the FOXC1 
transcriptional regulator. Molecular analysis showed that SLIT2 and/or ROBO2 
signalling is required to restrict Gdnf expression to caudal mesenchyme 
(Grieshammer et al., 2004). FOXC1 is also required for caudal restriction of 
Gdnf (Kume et al., 2000), but is not a target of SLIT2/ROBO2 signalling 
(Grieshammer et al., 2004). By contrast, SPRY1, an intra-cellular antagonist of 
tyrosine kinase receptors, reduces the sensitivity of the Wolffian duct to GDNF, 
such that only one ureteric bud forms (Basson et al., 2005; Chi et al., 2004). In 
Spry1-deficient mouse embryos, ectopic epithelial buds form and multiple- and 
hydroureters are formed, which results in phenotypes identical to the human 
CAKUT syndrome (Basson et al., 2005). However, ectopic expression of Spry2 
in the Wolffian duct sensitises the epithelium to GDNF signalling, which again 
results in formation of supernumerary epithelial buds (Chi et al., 2004). Hence, 
the current view is that the interaction of these different signal transduction 
cascades restricts GDNF expression and activity such that only one ureteric bud 
forms in the caudal-most part of the Wolffian duct (Basson et al., 2005; 
Grieshammer et al., 2004). Metanephric kidney development is then initiated by 
the onset of ureteric bud outgrowth, and invasion and induction of the 
metanephric mesenchyme under the influence of GDNF-RET signalling 
(Costantini, 2006).  
Wnt11 expression is activated in the epithelial tip of the ureteric bud and WNT11 
signalling is in turn required to propagate mesenchymal GDNF signalling, which 
results in establishment of an autoregulatory e-m feedback signalling loop 
(Majumdar et al., 2003). In Wnt11-deficient mouse embryos, Gdnf expression 
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remains lower and the number of epithelial branches is reduced. Conversely, 
the disruption of GDNF signal reception in Ret-deficient embryos reduces 
Wnt11 expression. Therefore, autoregulatory GDNF-WNT11 feedback signalling 
co-ordinately controls the progression of metanephric branching morphogenesis 
after initiation of ureteric bud outgrowth (Majumdar et al., 2003). During 
branching, the ureteric epithelial tips secrete additional signals (e.g. WNT9b) 
(Carroll et al., 2005), which induce nephrogenesis. Nephrogenesis is regulated 
by transcriptional activation of another WNT signal, WNT4 in the condensing 
mesenchyme. Mouse embryos that lack Wnt4 fail to form metanephric kidneys 
due to disruption of the mesenchyme to epithelial transition of the nephrogenic 
precursors (Stark et al., 1994).  
Several BMP ligands and their receptors are expressed during metanephric 
kidney organogenesis, but relatively little is known about their essential roles in 
these processes as loss-of-function mutations often cause early embryonic 
lethality. However, genetic inactivation of Bmp7 in mouse embryos leads to 
premature depletion of the nephrogenic mesenchyme, which manifests itself in 
a dysplastic kidney phenotype (Dudley et al., 1995; Luo et al., 1995). A recent 
study shows that BMP4 can compensate for the lack of Bmp7 during 
metanephric kidney development, which indicates that BMPs could potentially 
replace one another during kidney organogenesis (Oxburgh et al., 2005). 
Furthermore, a small fraction of mice heterozygous for a Bmp4 loss-of-function 
allele display CAKUT-like phenotypes and/or multicystic dysplastic kidneys 
(Miyazaki et al., 2000). This phenotype is likely caused by defects in ureteric 
stalk elongation, but treatment of metanephric kidney primordia with 
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recombinant BMP4 also interferes with epithelial branching morphogenesis in 
culture, which indicated that BMP4 activity may require dynamic modulation 
(Miyazaki et al., 2000; Raatikainen-Ahokas et al., 2000). Gremlin 1 (GREM1) is 
a member of the CAN domain family of extra-cellular BMP antagonists that 
binds BMP2 and BMP4 with highest affinity in vitro (Hsu et al., 1998). However, 
the ligands antagonised by GREM1 in vivo during vertebrate embryogenesis 
remained elusive to date. We recently showed that Grem1 is expressed by the 
meso and metanephric mesenchyme and that metanephric kidney 
organogenesis is disrupted in Grem1-deficient mouse embryos, resulting in 
bilateral renal agenesis and neo-natal lethality (Michos et al., 2004). In 
particular, metanephric kidney development is blocked at the stage of initiating 
of ureteric bud outgrowth. However, Gdnf expression is initially normal in the 
metanephric mesenchyme and the epithelium continues to express Ret. The 
block in initiating ureteric bud outgrowth causes progressive loss of Gdnf 
expression and elimination of the metanephric mesenchyme by apoptosis.  
In the present study, we established that culturing early Grem1-deficient kidney 
primordia in medium supplemented with recombinant GREM1 restores ureteric 
bud outgrowth and supernumerary epithelial buds are induced. Multiple 
epithelial buds invade the metanephric mesenchyme and initiate branching 
morphogenesis. Wnt11 expression in the epithelial tips and Gdnf expression in 
the metanephric mesenchyme around the epithelium is restored, which is 
indicative of establishment of e-m feedback signalling in GREM1-treated mutant 
kidney primordia. We identify excessive BMP activity in the metanephric 
mesenchyme around the ureteric bud as the primary signalling defect in Grem1-
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deficient mouse embryos. As a consequence, the invasion of the mutant 
metanephric mesenchyme by the ureteric bud and concurrent establishment of 
the autoregulatory GDNF/WNT11 feedback signalling loop are disrupted. 
Therefore, it was important to identify the BMP ligand(s) antagonised by GREM1 
in the mesenchyme. BMP4 was identified as a relevant BMP signal by its 
partially overlapping expression with Grem1 during initiation of ureteric bud 
outgrowth and by genetic complementation: inactivation of only one copy of the 
Bmp4 gene in Grem1-deficient mouse embryos completely restores 
metanephric kidney organogenesis and functions. We conclude that GREM1-
mediated reduction of BMP4 activity in the mesenchyme around the nascent 
ureteric bud is essential to (1) initiate ureteric bud outgrowth and invasion of the 
metanephric mesenchyme, and (2) enable autoregulatory e-m feedback 
signalling that regulates the dynamics of epithelial branching morphogenesis. 
 
Results 
The BMP antagonist gremlin 1 induces supernumerary epithelial buds and 
restores invasion and branching in Grem1-deficient kidney primordia. 
We have previously shown that metanephric kidney development arrests prior to 
initiation of ureteric bud outgrowth in Grem1-deficient mouse embryos (Michos 
et al., 2004). To gain insight into the functions of GREM1 during the inductive 
phase of metanephric kidney organogenesis, wild-type and Grem1-deficient 
metanephric kidney primordia (E11.0-11.25, 40-44 somites; expressing the 
Hoxb7-GFP transgene) (Srinivas et al., 1999) were cultured for up to 96 hours in 
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the presence or absence of soluble recombinant GREM1 protein. In contrast to 
wild-type controls (Fig. 1A), the development of Grem1-deficient kidney 
primordia arrests at the ureteric bud stage (Fig. 1B, n=13/16). Supplementation 
of the culture medium with GREM1 (5 µg/ml) restores ureteric epithelial 
outgrowth and branching (Fig. 1C,D; n=12/16) and induces several 
supernumerary epithelial buds (on average two to four; indicated by red 
asterisks in Fig. 1C,D). Most supernumerary buds appear within 48 hours and 
by 96 hours the ureteric and ectopic epithelial buds have undergone between 
two and four branching events (Fig. 1C,D). Epithelial tracings of the GREM1-
treated Grem1 mutants (right-most panels in Fig. 1C,D) reveals that branching 
of the ureteric bud is delayed by at least 24 hours in comparison to the wild-type 
(right-most panels in Fig. 1A,E). Ureteric epithelial outgrowth and branching are 
also restored and ectopic epithelial buds induced when mutant kidneys are 
cultured in the presence of less recombinant GREM1 (2 µg/ml; data not shown) 
or the unrelated BMP antagonist noggin (see Fig. S1). In wild-type, recombinant 
GREM1 also induces ectopic epithelial buds (red asterisks) and ectopic 
branches of the ureteric epithelium (blue asterisks, Fig. 1E). In general, 
treatment with soluble BMP antagonists induces more ectopic epithelial buds in 
the rostral part of the mutant Wolffian duct (red asterisks, Fig. 1C,D, and see 
Fig. S1) than in wild-type kidney primordia (red asterisks, Fig. 1E). Therefore, 
the potential for ectopic epithelial bud formation appears increased in the 
mutant, possibly due to the early developmental arrest of Grem1-deficient 
kidney primordia.  
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Fig. 1. Recombinant GREM1 protein is able to induce ectopic epithelial 
buds and restore branching in Grem1-deficient kidney primordia. Wild-type 
and Grem1-deficient kidney primordia expressing the Hoxb7-GFP transgene in 
their Wolffian duct and ureteric epithelium (Srinivas et al., 1999) were isolated 
from mouse embryos of 40-44 somites (E11.0-E11.25) and cultured for up to 96 
hours. Panels show from left to right: cultures at 0 hours, 24 hours, 48 hours, 72 
hours and 96 hours (time: ±2-3 hours). White asterisks indicate ureteric buds, 
red asterisks indicate ectopic epithelial buds and blue asterisks ectopic 
branches. The right-most panels are schematic tracings of the Wolffian duct and 
epithelial branching pattern at the developmental time points indicated (96 hours 
for Grem1 mutants; 72 hours for wild type). Wolffian duct and ureteric bud are 
shown in white; ectopic epithelial buds and/or outgrowth in yellow; first branch in 
red; second branch in blue; third branch in green; fourth branch in purple; fifth 
branch (A only) in orange. (A,B) Kidney primordia cultured in control medium. 
(A) Wild-type control. (B) Grem1-deficient metanephros; outgrowth and 
branching are blocked. (C-E) Grem1-deficient (C,D) and wild-type (E) kidney 
primordia cultured in medium supplemented with recombinant GREM1 (5 
µg/ml). The Grem1-deficient metanephric kidney primordia shown in C and D 
are representative of the variability observed. 
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In Grem1-deficient embryos, Ret continues to be expressed by the Wolffian duct 
and ureteric epithelium. Also Gdnf expression is initially normal, but is 
downregulated progressively and the mutant mesenchyme is eliminated by 
apoptosis (Michos et al., 2004). By contrast, the expression of Wnt11 in the 
mutant ureteric bud epithelium is lower than in the wild-type bud from the 
beginning and is completely lost by E11.5 (see Fig. S2). Therefore, Wnt11 and 
Gdnf provide good markers to monitor of e-m feedback signalling in Grem1-
deficient kidney primordia (Fig. 2). Mutant kidney rudiments (isolated from 
E10.75-11.0 mouse embryos; 38-40 somites) were cultured for 48 hours to 
avoid the onset of massive apoptosis (Fig. 2B,E and data not shown) and to 
allow treatment with recombinant GREM1 to restore ureteric bud outgrowth 
(white asterisks, Fig. 2C,F) and induce formation of ectopic buds (red asterisks, 
Fig. 2C,F). Indeed, GREM1 treatment restores Gdnf expression in the distal 
mesenchyme around the invading ureteric bud (white asterisk in Fig. 2C) and 
expression is also activated around the ectopic buds (red asterisks, Fig. 2C). 
Semi-quantitative RT-PCR analysis reveals that GREM1 treatment increases 
Gdnf transcript levels by at least twofold (see Fig. S3; 1.9±0.4, mean±s.e.m., 
n=3). In the ureteric epithelium, the expression of Wnt11 is no longer detected in 
Grem1-deficient kidney primordia after 48 hours (Fig. 2E) in contrast to the wild-
type primordia (Fig. 2D). Strikingly, GREM1 treatment of the mutant kidney 
primordia completely restores Wnt11 expression in the epithelial tips of the 
invading ureteric (white asterisk, Fig. 2F) and all ectopic (red asterisks, Fig. 2F) 
buds. This molecular analysis establishes that recombinant GREM1 is able to 
restore epithelial WNT11 signalling and thereby autoregulatory e-m feedback 
signalling and metanephric branching morphogenesis.  
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Fig. 2. Treatment with recombinant GREM1 enables upregulation and propagation of 
Wnt11 and Gdnf expression in Grem1-deficient kidney rudiments in culture. Mouse kidney 
primordia were isolated at E10.75-11.0 (38-42 somites) and cultured for 48 hours either without 
(A,B,D,E) or in the presence of recombinant GREM1 (5 µg/ml, C,F). All upper panels show the 
epithelial branching pattern as revealed by the Hoxb7-GFP transgene. Lower panels show 
transcript distributions as revealed by whole-mount in situ hybridisation. Ureteric buds are 
indicted by white asterisks, ectopic epithelial buds by red asterisks. (A-C) Gdnf expression: (A) 
wild-type control; (B) Grem1-deficient kidney primordia, note the smaller size and remaining 
Gdnf expression; (C) Grem1-deficient kidney primordia cultured in the presence of recombinant 
GREM1. Note the ectopic epithelial buds and Gdnf expression in the surrounding mesenchyme. 
(D-F) Wnt11 expression (D) wild-type control; (E) Grem1-deficient kidney primordia, note the 
complete loss of Wnt11 expression; (F) Grem1-deficient kidney primordia cultured in the 
presence of recombinant GREM1. Wnt11 is expressed in the epithelial tips of both ureteric and 
ectopic buds. 
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The responsiveness of the epithelium and mesenchyme in Grem1-deficient 
kidney primordia was further studied as follows: (1) By forced activation of 
canonical Wnt signal transduction in culture, nephrogenesis is activated (see 
Fig. S4), thereby establishing that the mutant metanephric mesenchyme 
remains responsive to inductive signals; (2) By culturing Grem1-deficient kidney 
primordia in an excess of recombinant GDNF (100 ng/ml; Fig. 3) massive 
epithelial overgrowth and branching are induced along the entire Wolffian duct 
similar to what occurs in wild type (Fig. 3A,B; see also Shakya et al., 2005). 
These results indicate that the block to initiate ureteric bud outgrowth and 
invasion of the mesenchyme is not caused by defective epithelial signal 
reception, but rather by defects in signalling, i.e. the failure to upregulate Gdnf 
expression in the mesenchyme and/or Wnt11 in the ureteric epithelium. 
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Fig. 3. Recombinant GDNF induces epithelial overgrowth and excessive branching in 
both wild-type and Grem1-deficient mouse metanephric kidney primordia. Kidney 
primordia (E11.0, 40-42 somites) were cultured for 96 hours in medium supplemented with 
recombinant GDNF (100 ng/ml). (A) Wild-type; note the formation of many epithelial buds along 
the Wolffian duct and overgrowth of the ureteric epithelium within 24 hours, which results in 
excessive branching. (B) Grem1-deficient kidney primordia; note the formation of many 
epithelial buds, overgrowth and excessive branching similar to the wild type (A). 
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The Grem1 deficiency causes aberrant nuclear accumulation of pSMAD 
proteins in the metanephric mesenchyme around the ureteric bud. 
The results so far reveal the importance of identifying the primarily affected 
kidney compartment and relevant BMP ligand(s). With respect to the latter, 
Bmp4 (in contrast to Bmp2 and Bmp7) (Michos et al., 2004) is expressed by the 
mesenchyme along the entire Wolffian duct, including the region where the 
ureteric bud is forming (Fig. 4C, compare with Fig. 4A, see also Fig. 4G). 
Therefore, the Wolffian duct and nascent ureteric bud are `embedded' in Bmp4- 
expressing mesenchyme. By contrast, the nascent metanephric mesenchyme is 
more or less devoid of Bmp4 expression during ureteric bud outgrowth and first 
branching (Fig. 4B,D). Subsequently, Bmp4 expression is (re-) activated in 
metanephric mesenchyme enveloping the ureteric stalk, consistent with its 
proposed functions during stalk elongation (Miyazaki et al., 2000) (and data not 
shown). Just prior to initiation of ureteric bud outgrowth, the highest levels of 
Grem1 transcripts are detected in the mesenchyme around the caudal Wolffian 
duct and nascent ureteric bud (Fig. 4E,H). Activation of Grem1 expression does 
not seem to require GDNF signalling, as Grem1 remains expressed in the 
metanephric kidney primordia of Gdnf mutant mouse embryos (see Fig. S3). 
After the first epithelial branching event, Grem1 expression is highest in the 
metanephric mesenchyme surrounding the ureteric epithelial tips (Fig. 4F). The 
transcriptional upregulation of Grem1 just prior to the onset of ureteric bud 
outgrowth (Fig. 4E,H) would likely inhibit BMP4 locally and generate a region of 
low mesenchymal BMP activity. Such regional lowering of mesenchymal BMP 
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activity likely relieves repression of ureteric bud outgrowth and enables its 
invasion into the metanephric mesenchyme in response to GDNF signalling. 
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Fig. 4. Dynamic changes in Grem1 and Bmp4 expression during initiation of metanephric 
kidney development in mouse. (A-D) Bmp4 distribution during initiation of metanephric kidney 
development. (A,B) GFP reveals the morphology of the nascent ureteric bud at E11.0 (40-42 
somites; A) and after the first epithelial branching (E11.5, 48-50 somites; B). Asterisks in B 
indicate the tips of the ureter branches. (C,D) The Bmp4 transcript distribution was determined 
using a lacZ reporter gene inserted into the endogenous Bmp4 transcription unit (Bmp4:lacZ) in 
heterozygous embryos (Kulessa and Hogan, 2002), as detection by whole mount in situ 
hybridisation is not reliable. (C) At E11.0, Bmp4:lacZ is expressed by the mesenchyme 
surrounding the Wolffian duct (arrow) and ureteric bud (see also G). The dotted circle indicates 
the position of the ureteric bud (compare with A). (D) By E11.5, the Bmp4:lacZ expression is 
retained in the mesenchyme surrounding the Wolffian duct (arrow), while the metanephric 
mesenchyme is largely devoid of Bmp4. The dotted line indicates the position of the first branch 
(compare with B). (E,F) Grem1 expression in the mesenchyme. (E) At E11.0, Grem1 expression 
is highest in the mesenchyme around the ureteric bud (indicated by a dotted circle). (F) 
Subsequently (E11.5), Grem1 is expressed in the mesenchyme around the tips of first ureteric 
epithelial branch (indicated by dotted oval). (G,H) Detection of Bmp4 and Grem1 transcripts on 
transverse sections by in situ hybridisation. Sections are oriented with dorsal to the top. Note 
that the epithelium (indicated by a dotted line) expresses neither Bmp4 (G) nor Grem1 (H). (G) 
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There is abundant Bmp4 expression in the mesenchyme around the caudal Wolffian duct and 
ureteric epithelium in agreement with the Bmp4:lacZ distribution shown in C. (H) At E10.75 (38 
somites), Grem1 is also expressed in the mesenchyme around the caudal Wolffian duct and 
ureteric epithelium in agreement with the whole mount in situ hybridisation shown in E. Note 
that Bmp4 and Grem1 are also expressed by the mesenchyme around the hindgut. Hg, hindgut; 
mm,: metanephric mesenchyme; wd, Wolffian duct. 
 
To determine if such lowering of BMP signal transduction indeed occurs, the 
phosphorylation of SMAD proteins (pSMAD1/5/8; established mediators of BMP 
signal transduction) (Massagué et al., 2005) was analysed in wild-type and 
Grem1-deficient mouse embryos (Fig. 5). During ureteric bud formation in the 
wild-type, the Wolffian duct and ureteric bud are largely devoid of nuclear 
pSMAD proteins (brown stained nuclei, Fig. 5A) as revealed by abundant 
Hoechst fluorescence (light blue nuclei, Fig. 5A). Whereas the pSMAD antigen 
is abundant in the ventral mesenchyme, only a few pSMAD-positive nuclei are 
apparent in the metanephric mesenchyme (demarcated region indicated by 
`mm' in Fig. 5A). By contrast, a significant fraction of the cells in the 
corresponding region of Grem1-deficient embryos contain pSMAD proteins in 
their nuclei and the metanephric mesenchyme appears overall less dense (Fig. 
5B). These results indicate that BMP signal transduction is lowered in the wild-
type metanephric mesenchyme during initiation of ureteric bud outgrowth (Fig. 
5A), whereas it remains excessively high in the mutant mesenchyme (Fig. 5B). 
In the wild type, the nuclear pSMAD levels remain low in both epithelium and 
condensing metanephric mesenchyme during invasion and first branching (Fig. 
5C,E), while they increase in stromal mesenchyme (Fig. 5C,E). This increase is 
81 
 
 
consistent with a role of BMP4 in ureteric stalk elongation (Miyazaki et al., 
2000). In Grem1 mutant kidneys, the aberrant pSMAD levels persist throughout 
the mutant metanephric mesenchyme, while the arrested ureteric bud 
epithelium remains largely devoid of nuclear pSMAD proteins (Fig. 5D,F). The 
low pSMAD levels in the wild-type metanephric mesenchyme (Fig. 5A,C) 
overlap well with the area normally expressing Grem1 (Fig. 4E,F). In summary, 
the aberrant and persistently high BMP(4) activity in the mutant metanephric 
mesenchyme reveals a primary defect in Grem1-deficient kidney primordia 
(Fig.5B,D,F) and sharply contrasts with the dynamic changes of BMP activity in 
the wild type (Fig. 5A,C,E).  
82 
 
 
 
Fig. 5. Detection of phosphorylated SMAD1/5/8 proteins (pSMAD) on tissue sections. The 
brown precipitate reveals pSMAD-positive nuclei. All sections are counterstained with Hoechst 
33258 (light blue fluorescence) to reveal nuclei lacking pSMADs. All sections are sagittal along 
the primary embryonic axis with ventral to the left and dorsal to the right. Sections shown are 
representative of the results obtained by analysing serial sections of at least three embryos per 
genotype. (A,C,E) Wild-type mouse embryos at E11.0 (40 somites; A); E11.25 (47 somites; C) 
and E11.5 (50 somites, enlargement of tip region; E). (B,D,F) Grem1-deficient embryos at E11.0 
(42 somites; B) and E11.25 (48 somites; D), an enlargement of the ureteric bud area in D is 
shown in F. The area within the red dashed line contains many picnotic nuclei indicative of the 
onset of cellular apoptosis (D,F). cm, condensing metanephric mesenchyme; mm, metanephric 
mesenchyme; sm, stromal mesenchyme; ub, ureteric bud; ue, ureteric epithelium (first branch); 
us, ureteric stalk; wd, Wolffian duct. 
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Genetic reduction of BMP4 activity in Grem1-deficient mouse embryos rescues 
metanephric kidney organogenesis and postnatal kidney functions 
To test the hypothesis that excess mesenchymal BMP4 activity blocks the 
initiation of ureteric bud outgrowth, compound mutant embryos and mice 
carrying both Grem1 and Bmp4 loss-of-function mutations were generated. The 
early lethality of Bmp4-deficient mouse embryos (Winnier et al., 1995) is not 
rescued by additional inactivation of Grem1, which precludes analysis of double 
homozygous embryos. However, inactivation of one copy of the Bmp4 gene in 
Grem1-deficient (G1 ∆/∆; B4 ∆/+) mouse embryos restores ureteric bud 
morphology (Fig. 6C, compare with Fig. 6A,B). In G1 ∆/∆; B4 ∆/+ mutant embryos 
(Fig. 6C,F,I,L), ureteric bud outgrowth and branching are initiated with kinetics 
similar to that in the wild type (Fig. 6A,D,G,J). Consistent with this rescue of 
epithelial outgrowth and branching, the expression of Gdnf in the mesenchyme 
(Fig. 6F,L, compare with Fig. 6E,K) and Wnt11 in the ureteric bud epithelium are 
restored (see Fig. S2 and data not shown), which is indicative of intact 
autoregulatory e-m feedback signalling during branching and normal 
progression of metanephric branching morphogenesis.  
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Fig. 6. Genetic inactivation of one copy of the Bmp4 gene in a Grem1 mutant background 
rescues the kinetics of ureteric epithelial growth and branching. Left panels: GFP reveals 
the morphology of the epithelium before fixation. Right panels: whole-mount in situ detection of 
the expression of the Ret receptor (A-C,G-I) and the Gdnf ligand (D-F,J-L). (A,D,G,J) Wild-type 
metanephric primordia. (B,E,H,K) Grem1 (G1 ∆/∆)-deficient metanephric primordia. Note the 
complete disruption of ampulla formation (E,H,K) and loss of mesenchymal Gdnf expression 
(K), whereas Ret expression remains in the arrested epithelium (H). (C,F,I,L) Metanephric 
primordia of G1 ∆/∆; B4 ∆/+ mouse embryos. Note the rescue of ureteric epithelial outgrowth (C), 
branching (F,I,L) and propagation of Gdnf expression (L). 
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Indeed, the distribution of the Pax2 transcript underscores the normal 
progression of kidney organogenesis in G1 ∆/∆; B4 ∆/+ embryos by E14.5 (Fig. 
7C, compare with Fig. 7A). By contrast, in Grem1-deficient embryos at this 
stage both kidneys have been eliminated by apoptosis (as revealed by the 
complete lack of Pax2 expression; Fig. 7B). All G1 ∆/∆; B4 ∆/+ mice are born with 
two fully developed and functional kidneys (Fig. 7G, compare with Fig. 7D; 
n=20), whereas complete bilateral renal agenesis is observed in about 90% of 
all Grem1-deficient litter mates (n=22/25; the other three manifested unilateral 
renal aplasia). Histological analysis of G1 ∆/∆; B4 ∆/+ mice at 1 and 8 months old 
reveals that their kidneys are morphologically indistinguishable from wild-type 
kidneys (Fig. 7E-I). No signs of congenital malformations such as CAKUT, 
glomerulosclerosis or polycystic kidney disease are observed (Fig. 7G,H,I). 
Taken together, these results show that the genetic reduction of BMP4 activity 
in Grem1-deficient mouse embryos completely restores metanephric kidney 
organogenesis and functions. 
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Fig. 7. Inactivation of one copy of the Bmp4 gene in a Grem1-deficient mouse embryo 
results in formation of two normal kidneys. (A-C) Whole-mount in situ hybridisation to detect 
Pax2 expression at E14.5. (A) Wild-type Pax2 distribution. (B) The absence of Pax2 expression 
in a Grem1-deficient embryo is due to the complete renal aplasia at this stage. (C) The Pax2 
distribution in kidneys of a Grem1 ∆/∆; Bmp4 ∆/+ embryo is indistinguishable from a wild-type 
littermate (A). (D) Gross morphology of the wild-type urogenital system at birth (postnatal day 
P0). (E) Haematoxylin and Eosin staining of a histological section of a wild-type kidney 30 days 
after birth (P30). (F) PAS staining reveals the morphology of the medulla (collecting ducts) and 
cortex regions of a wild-type kidney at about 8 months of age (P250). (G) Gross morphology of 
the urogenital system of a Grem1 ∆/∆; Bmp4 ∆/+ mouse at birth (P0). Note that both kidneys are of 
normal size and shape (compare with D). (H) Haematoxylin and Eosin staining of a kidney 
section from a Grem1 ∆/∆; Bmp4 ∆/+ mouse at P30. (I) PAS staining of a kidney from a Grem1 ∆/∆; 
Bmp4 ∆/+ mouse at P250. Medulla, cortex and glomeruli appear normal. Bl, bladder; cd, 
collecting duct; cx, cortex; gl, glomerulus; go, gonad; ki, kidney; md, medulla, tu, tubules. 
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SUPPLEMENTARY FIGURES 
 
 
Fig. S1. The BMP antagonist noggin induces ectopic epithelial buds, outgrowth and 
branching in cultured Grem1-deficient kidney primordia. (A) Culture of a Grem1-deficient 
metanephric primordia in control medium for 60 hours. (B) Culture of a Grem1-deficient (G1 ∆/∆) 
metanephric primordia in noggin-supplemented medium. After 48 hours, several ectopic 
epithelial buds have formed (red asterisks). The ureteric epithelium (white asterisk) has 
undergone its first branching by 48 hours and the second branching is initiated after about 60 
hours (n=6). 
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Fig. S2. Expression of Wnt11 in the ureteric bud epithelium depends on gremlin 1. (A-D) 
The expression of Wnt11 is lost from the ureteric bud epithelium of Grem1-deficient 
metanephric kidneys. Detection of Wnt11 transcripts at E11.0 (A,B) and E11.5 (C,D) in wild-type 
(A,C) and Grem1-deficient (B,D) kidney primordia. The approximate position of the mutant 
ureteric bud is indicated by a broken line in D. (E) Genetic reduction of Bmp4 activity in the 
context of a Grem1 deficiency (Grem1 ∆/∆; Bmp4 ∆/+) restores Wnt11 expression. Arrowheads 
point to the ureteric epithelial tips. ub, ureteric bud; ue, ureteric epithelial tip region expressing 
Wnt11 after first branching. 
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Fig. S3. Semiquantitative RT-PCR analysis Gdnf and Grem1 expression. (A) Determination 
of the relative Gdnf expression levels in wild-type (Wt) and Grem1-deficient (G1Δ/Δ) kidney 
primordia isolated at E10.75-11.0 (38-40 somites). RNA was isolated either at the time of 
dissection (Non-cultured) or after 48 hours in culture (Cultured) in medium alone or 
supplemented with recombinant gremlin 1 (5 μg/ml; lane G1 ∆/∆ +GREM1). Relative Gdnf 
transcript levels (upper row) after normalization for β-Actin mRNA content (lower row). As 
expected, the relative Gdnf levels and kidney primordia sizes are similar when wild-type (Wt) 
and Grem1 (G1 ∆/∆)-deficient kidney primordia are isolated at E10.75. After 48 hours in culture, 
one would expect lower levels of Gdnf transcripts in mutant kidneys (see Fig. 2B). However, 
due to the developmental arrest, the overall size of the mutant kidney primordia is significantly 
smaller than those of wild-type controls and mutants treated with gremlin 1 (G1 ∆/∆ Δ +GREM1; 
see Fig. 2B and compare with Fig. 2A,C; and data not shown). The normalization for β-Actin 
transcript content will also adjust for the smaller overall size; therefore, the relative Gdnf 
transcript levels of untreated mutants appear similar to wild-type controls after 48 hours in 
culture. Most importantly, treatment of Grem1 mutants with recombinant gremlin 1 protein 
(G1 ∆/∆ +GREM1) increases Gdnf expression levels about twofold (1.9±0.4, n=3) in comparison 
with untreated mutants (G1 ∆/∆) and wild-type controls. (B) Grem1 expression in wild-type and 
Gdnf-deficient kidney primordia isolated at E11.0 (40-44 somites). Note that Grem1 remains 
expressed at similar levels in Gdnf mutant (Gdnf ∆/∆) kidney primordia as in wild-type controls 
(Wt).
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Fig. S4. The metanephric mesenchyme of Grem1-deficient embryos remains 
competent to condense and initiate nephrogenesis. (A-C) Distribution of the PAX2 
protein in kidney primordia cultured for 72 hours. (A) PAX2 is present in both the 
epithelium and condensing mesenchyme of wild-type metanephric kidney primordia. (B) 
PAX2 is only retained in the epithelium of Grem1-deficient metanephric kidney primordia 
(arrowhead points to the tip of ureteric bud). (C) Culturing Grem1-deficient metanephric 
kidney primordia in the presence of 15 μM LiCl (+LiCl) induces mesenchymal 
condensation (Davies et al., 1995; Oxburgh and Robertson, 2002) as revealed by PAX2. 
LiCl induces nephrogenesis probably by activating canonical Wnt signal transduction (as 
it acts at the level of GSK3β) (Klein and Melton, 1996). Note that the ureteric epithelium 
has neither grown nor branched. Arrowheads (B,C) point to the distal tip of the ureteric 
bud. (D-F) 15 μM LiCl induces the isolated metanephric mesenchyme to condense as 
revealed by activation of the Wilm’s tumor-1 (WT1) protein. (D) Isolated wild-type and 
Grem1-deficient (data not shown) mesenchyme cultured without LiCl is eliminated by 
apoptosis. (E,F) LiCl treatment of both wild-type (E) and Grem1-deficient (F) 
mesenchyme induces the WT1 protein. (G-I) Wnt4 expression is activated in isolated 
metanephric mesenchyme cultured with 15 μM LiCl for 72 hours. (G) Wnt4 is not detected 
in mutant mesenchyme cultured without LiCl. (H,I) LiCl treatment induces Wnt4 
expression in to a similar extent in wild-type (H) and Grem1-deficient (I) mesenchyme, which indicates that nephrogenesis has been initiated. For 
immunodetection of PAX2 and WT1, kidney primordia were incubated overnight in a methanol:DMSO solution (4:1, 4°C) and incubated again overnight with 
either PAX2 (Covance, 1/500) or WT1 (Santa Cruz, 1/50) primary antibodies diluted in FBS:DMSO (4:1, 4°C). After washing in PBT/FBS/DMSO, samples 
were incubated overnight with secondary antibodies coupled to specific fluorochromes (Cy3 for WT1 and Cy2 for PAX2; Amersham) and washed extensively 
the following day. 
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Discussion 
Our study establishes genetically that the extra-cellular BMP antagonist GREM1 
is required to reduce BMP4 activity in the mesenchyme surrounding the nascent 
ureteric bud in mouse embryos. The reduction of BMP4 signal transduction in 
the metanephric mesenchyme is necessary to initiate ureteric bud outgrowth 
and establish autoregulatory feedback signalling between GDNF-RET and 
WNT11, which in turn regulates epithelial branching morphogenesis (Fig. 8). In 
Grem1-deficient kidney primordia, mesenchymal BMP signal transduction is 
increased, as revealed by the increased nuclear accumulation of pSMAD 
proteins in the metanephric mesenchyme, which blocks initiation of ureteric bud 
outgrowth. Indeed, general inhibition of BMP activity in Grem1-deficient kidney 
primordia, by addition of recombinant GREM1, induces supernumerary epithelial 
buds and restores outgrowth and branching. At the molecular level, GREM1 
treatment (re-) activates Wnt11 expression in the epithelial buds and enables 
upregulation and propagation of Gdnf expression in the mesenchyme. Most 
importantly, genetic reduction of BMP4 activity in the context of a Grem1 
deficiency completely restores metanephric kidney organogenesis and 
functions. Therefore, we can conclude that local reduction of BMP4 activity by 
GREM1 is vital to initiate ureteric bud outgrowth and thereby metanephric 
kidney organogenesis (Fig. 8).  
Formation of the ureteric bud, initiation of its outgrowth and branching appear as 
distinct processes (Fig. 8). In the metanephros, a single ureteric bud forms in 
the caudal part of each of the bilateral Wolffian ducts at the level of the mid-hind 
limb bud. GDNF is essential for ureteric bud formation, as ureteric buds fail to 
92 
 
 
form in most Gdnf-deficient mouse embryos (Pichel et al., 1996). As Grem1 
remains expressed in Gdnf mutant metanephric kidney rudiments, the activation 
of its expression does not depend on GDNF signalling and seems not to require 
the presence of an intact ureteric bud. Interestingly, recombinant GREM1 is 
itself able to induce supernumerary epithelial buds in Grem1-deficient kidney 
primordia. These results indicate that in spite of the early developmental arrest, 
the competence of the rostral Wolffian duct to form supernumerary epithelial 
buds remains intact in Grem1-deficient embryos. In wild-type embryos, the 
signalling interactions mediated by SLIT2/ROBO2 and FOXC1 restrict Gdnf 
expression to the caudal Wolffian duct (see Introduction and references therein). 
We provide evidence that BMP4 signalling by the mesenchyme enveloping the 
Wolffian duct is part of a safeguard mechanism that inhibits formation of 
supernumerary epithelial buds (Fig. 8A). Local upregulation of Grem1 
expression reduces pSMAD-mediated BMP signal transduction in the 
mesenchyme and relieves this repression around the ureteric bud, which 
enables ureteric bud outgrowth and invasion of the metanephric mesenchyme 
(Fig. 8B). Taken together, the successful initiation of ureteric bud outgrowth 
likely requires both antagonism of BMP4 by GREM1 in mesenchyme and 
signalling by GDNF from the metanephric mesenchyme to RET in the ureteric 
epithelium (Fig. 8A,B).  
Subsequently, autoregulatory feedback signalling between GDNF in the 
mesenchyme and WNT11 in the epithelial tips is established to regulate 
branching morphogenesis (Fig. 8C; Majumdar et al., 2003). As GREM1 is 
required for upregulation of Wnt11 in the ureteric epithelium and Gdnf 
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expression in the mesenchyme, it appears to be crucial for establishment of e-m 
feedback signalling (Fig. 8C).  
 
Fig. 8. Reduction of BMP4 activity by gremlin 1 in the mesenchyme around the ureteric 
bud is essential to enable ureteric epithelial outgrowth, GDNF-RET and WNT11-mediated 
e-m feedback signalling and branching morphogenesis. (A) In mouse, the ureteric bud 
forms in the caudal-most part of the Wolffian duct under the influence of GDNF-RET signalling. 
During this inductive period, Bmp4 is expressed by the mesenchyme enveloping the Wolffian 
duct. High levels of mesenchymal BMP4 activity inhibit the formation of ectopic epithelial buds 
and epithelial branching at this stage (prior to E11.0). At this early stage only low levels of 
Grem1 transcripts are detected (not shown). (B) Expression of the BMP antagonist Grem1 is 
upregulated in the mesenchyme around the nascent ureteric bud thereby locally reducing BMP4 
signal transduction (around E11.75-11.0). This reduction of BMP4 activity by GREM1 enables 
initiation of ureteric bud outgrowth and its invasion into the metanephric mesenchyme. (C) 
GREM1 is required to maintain and propagate expression of Wnt11 in the ureteric epithelial 
tip(s) and Gdnf in the mesenchyme via e-m feedback signalling. For details see Discussion. 
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As BMP signal transduction is increased in the metanephric mesenchyme of 
Grem1-deficient embryos, one might expect a direct effect of GREM1 and/or 
BMP4 on mesenchymal Gdnf expression. However, treatment of isolated 
metanephric mesenchyme with either GREM1 or BMP4 did not alter Gdnf 
expression significantly within 18-24 hours (O.M. and R.Z., unpublished). 
Therefore, we favour an alternative explanation, by which the primary defect 
(elevated BMP4 activity) in the Grem1-deficient metanephric mesenchyme 
blocks initiation of ureteric epithelial outgrowth and signalling as evidenced by 
the loss of Wnt11 expression. GREM1-mediated reduction of BMP activity in the 
mesenchyme may act via epithelial signalling to propagate mesenchymal Gdnf 
expression, analogous to the requirement of GREM1 for Shh expression in the 
limb bud mesenchyme (see below). Further (genetic) studies are required to 
understand how excess BMP signal transduction in the mesenchyme blocks 
initiation of ureteric bud outgrowth. In agreement with our studies, others have 
already shown that (1) addition of recombinant BMPs to metanephric kidney 
primordia in culture partially inhibits epithelial branching morphogenesis (Bush 
et al., 2004; Piscione et al., 1997), and (2) overexpression of the BMP receptor 
type 1A (ALK3; also known as BMPR1A-Mouse Genome Informatics) in the 
ureteric epithelium causes renal aplasia or dysplasia in a fraction of mice (Hu et 
al., 2003). 
Last but not least, the present study reveals striking mechanistic similarities in 
the way GREM1-mediated e-m feedback signalling controls limb and kidney 
organogenesis. During limb bud development, GREM1-mediated BMP4 
antagonism is key to establishing and propagating the feedback signalling loop 
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between SHH (expressed by the posterior mesenchyme) and FGF (in the apical 
ectodermal ridge, AER), which enables progression of limb bud 
morphogenesis(Michos et al., 2004; Panman et al., 2006; Zuniga et al., 1999). 
Our previous studies showed that GREM1 is not required to initiate SHH 
signalling by the limb bud organiser in the posterior mesenchyme, but is 
essential to initiate the dynamic phase of SHH/FGF e-m feedback signalling. In 
particular, GREM1-mediated SHH/FGF feedback signalling regulates the 
temporally and spatially coordinated propagation of both signalling centres 
during limb bud outgrowth and patterning (Panman et al., 2006). Similarly, 
GREM1 is not required to activate GDNF signalling in the metanephric 
mesenchyme and for formation of the ureteric bud, but for initiation of epithelial 
outgrowth and establishment of autoregulatory GDNF/WNT11 e-m feedback 
signalling. In both the limb and kidney primordia, GREM1 acts in the 
mesenchyme to reduce BMP4 signal transduction and thereby relieve the 
inhibitory effect on the ureteric and AER epithelium (this study and J.D. Bénazet 
and R. Z., unpublished). As a consequence, the expression of Wnt11 in the 
ureteric bud and Fgfs in AER are upregulated and this epithelial signalling in 
turn propagates GDNF in the metanephric, and SHH in the limb bud, 
mesenchyme, respectively. 
 
96 
 
 
VIII. GENETIC ANALYSIS OF THE BMP7-GREMLIN1 
INTERACTIONS DURING KIDNEY EPITHELIAL BRANCHING 
 
Summary 
Molecular and genetic studies revealed a requirement of Gremlin1 (Grem1)-
mediated antagonism of Bone Morphogenetic Protein 4 (BMP4) activity for 
initiation of metanephric kidney organogenesis. GREM1 in the caudal-most part 
of the metanephric mesenchyme inhibits BMP4 locally to enable 
GDNF/RET/Wnt11 feedback signalling. In vitro culture of kidney rudiments with 
GREM1 induces ectopic ureteric buds (UB). Temporally controlled inactivation 
of Bmp4 in vivo by tamoxifen induced recombination (see Appendix 1) 
suggested that BMP signalling inhibits formation of ectopic UBs. However, 
ectopic UBs are a response to localised inactivation of Bmp4 unlike the effects 
of general BMP antagonism, achieved by recombinant GREM1 application in 
vitro. These results suggest that several BMP family members might function in 
at least a partially overlapping manner in this process. Indeed, genetic 
inactivation of Bone morphogenetic Protein 7 (Bmp7) in a Grem1-deficient 
background restores the initiation of UB outgrowth and epithelial branching. 
These studies reveal a self-propagating system for progression of kidney 
development as revealed by the onset of nephrogenesis. Analysis of Six2 
expression reveals the partial restoration of the Grem1 deficient phenotype but 
is not sufficient to rescue the dysplastic Bmp7 ∆/∆ deficiency. This was confirmed 
using the kidney glomeruli marker PODOCALYXIN and the collecting system 
epithelia marker CYTOKERATIN. The comparison of Grem1; Bmp4 and Grem1; 
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Bmp7 compound mutants indicates that Six2 is normally regulated by both 
BMPs. These results indicate that GREM1 mediated BMP antagonism reduces 
overall BMP activity in a spatially restricted manner rather than only affecting 
either BMP4 or BMP7. The local reduction of BMP signalling permits initiation of 
UB outgrowth while BMP4 is then specifically required for UB stalk elongation 
(Miyazaki et al., 2000) and BMP7 for expansion of  SIX2 positive progenitors 
(Self et al., 2006). 
 
Introduction 
Genetic studies revealed that the BMP7 null mutation in mice develops defects 
in the skeleton, kidney and eye (Jena et al., 1997). Bmp7 expression is initiated 
during gastrulation at around E7.5. The metanephric mesenchyme (MM) 
expresses high levels of Bmp7 at the time of inductive interaction with the 
ureteric bud (UB) and at later stages it is expressed in the developing glomeruli, 
distal tubules and collecting ducts. BMP7 inhibits cell proliferation and induces 
cell differentiation. In the kidney, Bmp7-null mice present well formed proximal 
convoluted tubules but formation of distal convoluted tubules is disrupted 
(Godin et al., 1999). Distal convoluted tubules are responsible for Ca2+ 
absorption hence ossification defects are expected (Berry and Floyd C, 1989). 
Furthermore, the few surviving Bmp7∆/∆ newborn mice develop unilateral or 
bilateral polycystic kidneys and die shortly after birth. Most importantly, BMP7 is 
required to ensure the survival and proliferative expansion of the nephrogenic 
progenitors in the metanephric mesenchyme (Dudley et al., 1995).  
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Oxburgh and colleagues (Oxburgh et al., 2005) showed that BMP4 can 
substitute for loss of BMP7 during kidney development. Receptor occupancy by 
either BMP4 or BMP7 activates the same signalling pathways in the kidney. 
BMP type-I receptors Alk2 (activin receptor-like kinase-2) and Alk3 (activin 
receptor-like kinase-3) knock-out mice display similar phenotypes. They are 
both embryonic lethal, Alk2 by E7.5 and Alk3 at around E9.5, and animals 
carrying any of the transgenes present a normal nephron number (Martinez et 
al., 2002; Mishina et al., 1995; Mishina et al., 1999). However, another finding 
puzzled the previous assumption that both receptors were equivalent. The renal 
aplasia/dysgenesis or medullary dysplasia in mutants over-expressing ALK3 
throughout the ureteric epithelium was not expected, but it is possibly due to 
differential transducing activities depending of the combination of ligands during 
early development (Cain et al., 2008; Hu et al., 2003).  
To investigate which are the relevant BMP ligand(s) antagonised by Grem1 
during kidney and limb organogenesis we have undertaken different research 
strategies. We showed that GREM1 is required to modulate BMP signalling and 
that the genetic reduction of Bmp4 is sufficient to restore kidney development in 
a Grem1 -deficient background (Michos et al., 2007). Furthermore, we have 
shown that GREM1-mediated BMP4 antagonism is part of the 
SHH/GREM1/FGF signalling feedback loops which provides limb development 
with robustness (Bénazet et al., 2009). This study also revealed that GREM1 
also antagonises BMP7 during limb bud development albeit less efficiently.  
Indeed, the genetic inactivation of Bmp7 restores kidney development in the 
context of the Grem1 deficiency. However, unlike Bmp4, both Bmp7 allele 
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copies must be inactivated to restore initiation of branching morphogenesis. At 
a later stage, it is known that loss of Bmp7 results in depletion of the 
nephrogenic progenitor pool. We now reveal that the genetic inactivation of 
Grem1 in a Bmp7 null background improves the nephron defects.  
This analysis reveals that unlike in Grem1∆/∆; Bmp4∆/+ embryos only initiation 
and early UB branching morphogenesis are restored in embryos lacking both 
Grem1 and Bmp7, while nephrogenesis as a whole is still impaired. 
 
Results 
Complete genetic inactivation of Bmp7 restores the failure to initiate branching 
morphogenesis in Grem1 deficient kidneys  
We previously demonstrated that GREM1 mediated antagonism of BMP4 is 
required to initiate branching morphogenesis. 
To analyse the BMP7-GREM1 interaction during kidney organogenesis it was 
important to consider the following two issues: 1) is the reduction of Bmp7 
activity sufficient to restore the Grem1∆/∆ phenotype (failure to induce UB 
outgrowth) and 2) is the reduction of the Grem1 activity able to restore the 
Bmp7 loss-of-function phenotype (depletion of nephrogenic progenitors). 
To address the first issue, an allelic series of Bmp7 loss-of-function mutation in 
a Grem1 deficient background was analysed (Fig1 and Fig.S1). As shown, 
Grem1 deficient mice display bilateral renal aplasia, which is fully penetrant in a 
mixed F1 129/C57BL6 genetic background (Michos et al., 2007). However, if 
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the C57Bl6 component is increased, the Grem1 phenotype can vary from none 
to two kidneys – which reveals the importance of genetic background for the 
renal phenotypes. It suggests that BMP activity is tightly regulated during kidney 
development.  
In both Grem1 and Bmp7 heterozygous embryos/mice kidney development was 
not affected and the same was observed in the trans-heterozygous (data not 
shown). In contrast, a 50% reduction of Bmp7 in a Grem1∆/∆ background 
(Grem1∆/∆; Bmp7∆/+) displayed a phenotypic variability (Table1).  
 
Table 1 - Kidney agenesis - Genetic analysis of Grem1; Bmp7 compound mutant newborn 
mice. 
 
Genotypes     2 kidneys     1 Kidney          0 kidneys      Total 
     
Grem1∆/∆      0  1   (10%)       9   (90%)        10  
Grem1∆/∆; Bmp7∆/+ 
Grem1∆/∆; Bmp7∆/∆ 
     1   (5,0%) 
     8   (89%) 
   2   (10%) 
   1   (11%) 
    17   (85%) 
      0 
       20 
         9 
Grem1∆/+; Bmp7∆/∆ 
Bmp7∆/∆ 
   14   (93%)  
     5 (100%) 
   1   (2,4%) 
 0 
      0 
      0 
       15 
         5 
                                                                                                                    
 
The observed abnormalities in Grem1∆/∆; Bmp7∆/+ newborn mice varied from 
complete kidney agenesis (17 out 20) to the formation of 2 hypoplastic kidneys 
(1 out of 20). By doing the appropriate genetic crosses we were able to exclude 
that variability in penetrance of the renal agenesis was a mere genetic 
background effect (see Materials and Methods). In conclusion, in most of the 
Grem1∆/∆; Bmp7∆/+ mice the renal agenesis is not rescued in contrast to normal 
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progression of kidney development in Grem1∆/∆; Bmp4∆/+ mice. Analysis of the 
hypoplastic kidneys formed at low frequency in Grem1∆/∆; Bmp7∆/+ (Sup. Fig. 
1A) revealed their striking similarity to Grem1∆/∆; Bmp7∆/∆  kidneys (Fig. 2D-F).  
As reducing Bmp7 activity by 50% was not sufficient to restore kidney 
development, we anticipated that complete inactivation of Bmp7 is necessary. 
Indeed, the majority of all (89%) Grem1∆/∆; Bmp7∆/∆  newborn mice displayed 
two hypoplastic kidneys (Fig.1E, F and Table 1) in comparison to wild-types 
(Fig. 1A, B). Although no hydroureters were observed, the reduced kidney size 
may be due to the premature loss of nephrogenic progenitors which is 
responsible for the Bmp7∆/∆ phenotype (Dudley et al., 1995). Histological 
sections indeed reveal the much thinner cortex region (indicated with Cx) and 
fewer glomeruli in Grem1∆/∆; Bmp7∆/∆  in comparison to the wild-type mice 
(Fig.1B, C and Fig.1F, G). This indicates that genetic inactivation of Bmp7 does 
restore the early Grem1 defect in initiation of UB outgrowth and mesenchymal 
apoptosis due to excess of BMP signalling, but fails to restore the depletion of 
mesenchymal progenitors due to lack of Bmp7. However, comparison of 
Bmp7∆/∆ kidneys to Grem1∆/∆; Bmp7∆/∆ kidneys (Fig.1A-D and Fig. 1I-L) reveals 
that hydroureters formation was prevented and that the cortex region was 
slightly enlarged resulting in a bigger kidney size in double mutants (compare 
the kidneys and respective sections – Fig.1A, B, C and Fig. 1I, J, K). However, 
the major phenotype due to the importance of Bmp7 as a mesenchymal survival 
factor (Godin et al., 1998) was not completely restored. Hence this direct 
genetic comparison indicates that the GREM1/BMP7 interactions are possibly 
different from the GREM1/BMP4 antagonistic interactions. 
 102 
Fig. 1. Inactivation of both Bmp7 alleles restores the Grem1∆/∆ 
kidney agenesis phenotype but not the Bmp7∆/∆ phenotype 
resulting in depletion of nephrogenic progenitors. (A, E, I) Gross 
morphology of the urogenital system at birth. (B, F, J)  Haematoxylin 
and Eosin staining of histological sections of urogenital ridges from 
newborn mice. (C, G, K) Magnification of the kidney cortex regions. 
(D, H, L) Magnification of the medullar region. The Grem1∆/∆; Bmp7∆/∆ 
urogenital ridge displays two hypoplastic kidneys (compare E with A). 
The double-mutant kidney sections reveal the morphology of the 
hypoplastic small kidneys (F – compare with B). Magnification of the 
cortex area (G) reveals a thin cortex with scarce glomeruli and the 
medulla (H) is abnormal and poorly defined – compare to the wild-
type sections (panels C and D). Bmp7∆/∆ kidneys (I) more severely 
affected as they are even more reduced in size in comparison to wild-
type and double mutant kidneys (A). A detailed magnification of 
section J shows that the cortex is severely depleted as only a few 
glomeruli are detected and cysts are apparent. Note that the 
Grem1∆/∆; Bmp7∆/∆ (E-H) are bigger than the Bmp7∆/∆ kidneys (I-L) 
and less affected by cysts. Magnifications: kidney ridges 1.25x ; 
sections gross morphology: 4x ; sections high magnification: 40x. Cx, 
cortex; Cy, cyst; M, medulla 
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Inactivation of Grem1 improves glomeruli and collecting duct formation in Bmp7 
deficient kidneys 
To examine the formation of glomeruli and the collecting duct system, an 
immune detection assay was performed using the podocyte marker 
PODOCALYXIN (red) (Schmidt-Ott et al., 2006) and the anti-pan 
CYTOKERATINS 1, 5, 6, 8 (green) that marks the epithelium of the collecting 
ducts (Fig.2; Achtstatter et al., 1985). 
In wild-type sections, PODOCALYXIN and CYTOKERATIN (Fig. 2A-C) revealed 
the normal glomerular morphology and number (red) and the epithelial tree of 
the collecting duct system (green). Comparing wild-types to Grem1∆/∆; Bmp7∆/∆ 
kidneys (Fig. 2D-F) revealed the major defects. There is an overall decrease in 
the number of glomeruli and some cysts were readily observed in the cortex 
region, because they are delineated by epithelial cells (compare Fig. 2D with 
Fig. 2A). CYTOKERATIN staining showed that the fewer glomeruli that formed 
are properly connected to the collecting duct system (Fig. 2D-F), in agreement 
with normal urine secretion observed in some of the newborn mice. In contrast, 
Bmp7∆/∆ kidneys are severely malformed as previously described (Fig. 2G-I; 
Dudley et al., 1995). They appear smaller than the Grem1∆/∆; Bmp7∆/∆ kidneys 
and fewer normal looking glomeruli are formed (Fig. 2G and Fig. 2D). The 
cortex region is further reduced and the reduced nephrogenic area is poorly 
defined as some epithelial ducts seem to invade the cortex, indicative of a 
severely dysplastic phenotype. The Bmp7 deficient kidney displays a larger 
number of cysts. Moreover, abnormal glomeruli, indicative of a 
glomerulosclerosis phenotype, were detected with PODOCALYXIN with a 
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higher incidence in Bmp7 deficient than double mutant kidneys. Both gross 
morphology (Fig. 1 and Sup. Fig.1) and immunohistochemistry (Fig. 2) analysis 
indicate that additional inactivation of Grem1 is able to partially restore the 
kidneys phenotype caused by the Bmp7 deficiency, which indicates that Grem1 
modulation of BMP signalling is also required for robust nephron and ureter 
branching at later stages.  
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Fig. 2. Detection of PODOCALYXIN (red) to assess glomerular 
morphology and CYTOKERATIN (green) to reveal the collecting 
system. (A, D, G) Detection of PODOCALYXIN (red) and CYTOKERATIN 
(green) in newborn kidneys sections. (B, E, H) Magnification of 
PODOCALYXIN distribution in the cortex region. (C, F, I) Magnification of 
the medullar region showing the CYTOKERATIN distribution. Grem1∆/∆; 
Bmp7∆/∆ kidneys are smaller than wild-types (compare A and D) and show 
less glomeruli, evidenced by podocytes positive for PODOCALYXIN (A, B 
and D, E). The Bmp7∆/∆ kidney is even more hypoplastic than the 
Grem1∆/∆; Bmp7∆/∆, with a thinner nephrogenic region and less glomeruli – 
note the abnormal, collapsed morphology of some glomeruli (D, E and G, 
H). Both Grem1∆/∆; Bmp7∆/∆ and Bmp7∆/∆ kidneys develop cysts that are 
better visualized by CYTOKERATIN detection (D and G). The epithelial 
collecting duct system was labelled with CYTOKERATIN and reveals that 
the collecting duct trees are reduced, but potentially functional in the 
mutant kidneys (D, F, G and I). Confocal microscope magnifications: A, D,              
                                                                                                                                    G 10x ; B, C, E, F, H, I 20x. Cx, cortex; Cy, cyst; M, medulla. 
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Inactivation of Bmp7 in Grem1∆/∆ kidney rudiments restores the 
GDNF/Ret/Wnt11 feedback signalling loop and onset of nephrogenesis  
To gain insight into the extent of restoration of kidney development we 
performed a comparative molecular analysis of the Gdnf/Ret/Wnt11 feedback 
signalling loop in Grem1; Bmp7 deficient mouse embryos (Fig.3A-H). 
Furthermore, we also investigated whether the metanephric mesenchyme was 
competent to undergo nephrogenesis by analysing the expression of Pax2 
(Fig.3I-L) at E11.5.  
Ret expression was detected both along the Wolffian duct and in the epithelial 
tips of the invading and branching ureteric bud (Fig.3A-D). At E11.5 Grem1∆/∆ 
kidney rudiments already undergo apoptosis (Michos et al., 2004) and Ret 
expression is already lost (Fig. 3B – compare with wild-type panel A).  
These results show that complete inactivation of Bmp7 restores the Grem1-null 
phenotype (Fig. 3C). Bmp7 inactivation not only triggered initiation of epithelial 
branching but also prevented the metanephric mesenchyme to undergo 
apoptosis. Indeed, Wnt11 was also expressed by branching ureteric bud tips 
(Fig. 3E, G, H). Although Gndf expression was not analysed, these results 
indicate that complete Gdnf/Ret/Wnt11 feedback signalling is restored in the 
Grem1∆/∆; Bmp7∆/∆ kidneys. Wnt11 is only up-regulated following activation of 
the RET receptor by the GDNF ligand (Majumdar et al., 2003), which in turn 
permits propagation of epithelial-mesenchymal interactions and branching 
morphogenesis. In contrast, Wnt11 was not detected in the Grem1 deficient 
while it was properly expressed in Bmp7∆/∆  embryonic kidneys (Fig. 3F and H). 
Pax2 transcripts were expressed normally in the Wolffian duct of all genotypes 
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except Grem1∆/∆ embryos (Fig. 3I-L). The mesenchymal expression in the 
induced metanephric mesenchyme, indicative of the onset of nephrogenesis, 
was observed in the double mutant kidneys (Fig.3K – compare with panel I) and 
Bmp7∆/∆ (Fig. 1L), but not Grem1 deficient kidney rudiments. 
 
 
Fig. 3. Complete inactivation of Bmp7 in a Grem1 deficient background restores the 
GDNF/Ret/Wnt11 feedback signalling loop and epithelial branching morphogenesis. 
In situ hybridization with Ret (A-D), Wnt11 (E-H) and Pax2 (I-L) using mouse embryonic kidneys 
at E11.5-11.75 (49-54 somites). Ret expression was detected in the Wolffian duct epithelia of all 
samples. Ret transcripts were observed in tips of the branching epithelial ureteric bud (A, C, D) 
but not identified in Grem1∆/∆ kidney rudiments (B). Inactivation of Bmp7 in Grem1∆/∆ embryos 
restores branching morphogenesis as shown by up-regulation of Ret (compare B with C). Bmp7 
deficient embryonic kidneys display normal Ret expression (D). Wnt11 expression analysis (E-
H) parallels Ret levels. Normal Wnt11 expression is observed in Grem1∆/∆; Bmp7∆/∆ (G) and in 
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the Bmp7∆/∆ kidney rudiments (H) but absent from Grem1∆/∆ early kidneys (F). Pax2 expression 
was normal in the mesenchyme surrounding the Wolffian duct and the induced metanephric 
mesenchyme of the wild-type (I), Grem1∆/∆; Bmp7∆/∆ (J) and Bmp7∆/∆ kidney rudiments (L). Pax2 
transcripts are lost from Grem1∆/∆ embryonic kidneys (J) due to apoptosis of the metanephric 
mesenchyme (Torres et al., 1995). 
 
Six2 positive nephrogenic progenitors are partially restored in Grem1∆/∆; 
Bmp7∆/∆ embryos 
It has been shown that Six2 marks the nephron progenitor cell population in the 
metanephric mesenchyme (Kobayashi et al., 2008). Therefore Six2 was used to 
reveal the pool of nephrogenic progenitors in the different mutant genotypes. 
The Six2 in situ hybridization of E11.5 kidney rudiments revealed its rather 
unaltered expression in all relevant genotypes (Fig. 4A-D). In Grem1∆/∆ 
embryonic kidneys Six2 was only slightly down-regulated (compare Fig. 4A with 
Fig. 4B), which appeared restored to wild-type levels in Grem1∆/∆; Bmp7∆/∆ (Fig. 
4A, C). At this early stage, Six2 transcripts levels were also normal in Bmp7∆/∆ 
embryonic kidneys (Fig. 4D – compare with the wild-type in panel A). As 
previous studies showed that the Bmp7 loss-of-function phenotype only 
becomes evident around E13.5 (Jena et al., 1997), such stage and later kidney 
rudiments were also analysed. Indeed, branching morphogenesis is altered in 
Bmp7∆/∆ embryos by E13.5 (Fig. 4D) and Six2 transcript levels are lower 
(compare with the wild-type in panel E). It is also evident that the metanephric 
mesenchyme, where Six2 is normally expressed, appears rather reduced 
possibly due to the defects in branching morphogenesis. A very similar 
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reduction is seen in Grem1∆/∆; Bmp7∆/∆ kidneys (Fig. 4G). In contrast Six2 
expression is lost in Grem1∆/∆ kidney rudiments due to apoptosis (Fig. 4F). The 
analysis of the E14.5 kidney rudiments (Fig. 4I-L) confirmed these alterations. 
Residual Six2 expression was observed in Grem1∆/∆; Bmp7∆/∆ kidneys (Fig. 4K) 
in contrast to Grem1 deficient kidneys (Fig. 4J). Bmp7∆/∆ kidneys appeared 
smaller and Six2 was only weakly detected (Fig. 4L).  
 
Fig. 4. Six2 expression in metanephric nephron progenitors highlights the partial 
restoration of kidney development in Grem1∆/∆ embryos by Bmp7 inactivation. 
Six2 whole-mount in situ hybridization reveals the Grem1 and Bmp7 inactivation phenotypes. 
Kidney rudiments isolated at E11.5 (A-D) show rather normal Six2 expression. While expression 
is slightly decreased in Grem1∆/∆ kidneys (compare with wild-type in panel A) the double 
mutants (C) show close to normal expression. The Bmp7 deficient embryonic kidneys also 
express Six2 at normal levels (D). By E13.5 Grem1 deficient kidneys have been eliminated by 
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apoptosis (F) but in Grem1∆/∆; Bmp7∆/∆ embryos Six2 expression was reduced but not lost (G). 
Bmp7∆/∆ kidneys (H) express similar Six2 levels as the Grem1∆/∆; Bmp7∆/∆ kidneys. By E14.5 the 
Grem1∆/∆; Bmp7∆/∆ embryonic kidneys (K) are bigger than the Bmp7∆/∆ (L), but clearly smaller 
than wild-types (I). In both mutant genotypes Six2 expression levels are very much reduced.  
 
Comparative analysis of the Grem1, Bmp4 and Bmp7 expression patterns 
during early kidney development  
In summary the genetic and molecular analysis suggests that GREM1 regulates 
the activity of different BMP ligands during kidney development (see also 
chapter VII). Therefore the spatiotemporal expression patterns of Grem1, Bmp4 
and Bmp7 during early kidney development was assessed (Fig. 5). The 
epithelial expression of the Hoxb7- GFP transgene marks the Wolffian duct and 
the ureteric epithelium (Fig. 5A-D). Grem1 is expressed at rather low levels (Fig. 
5E-H). By E10.5 the expression is detected in the mesenchyme adjacent to the 
Wolffian duct and around the emerging epithelial ureteric bud (Fig. 5E). As 
development proceeds, the expression is maintained around the Wolffian duct 
and Grem1 transcripts remain around the ureteric bud at the ampullae stage 
(Fig. 5F). Subsequently it becomes restricted to the metanephric mesenchyme 
around the ureteric bud tips (Fig. 5G, H). To detect Bmp4 expression levels in 
embryonic kidneys we took advantage of the presence of the LacZ gene 
inserted into the Bmp4 locus and whose expression is under the control of the 
Bmp4 promoter. Interestingly, Bmp4 expression was low whenever Grem1 
expression was high (compare Fig. 5I-L with Fig. 5E-H). In contrast Bmp7 
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expression (Fig. 5M-P) appear to overlap at least partially with the one of 
Grem1 (compare Fig- 5E-H with panels M-P).  
 
 
 
 
 112 
Fig. 5. Spatiotemporal analysis of Grem1, Bmp4 and Bmp7 expression 
during early kidney development. Embryonic kidney rudiments were isolated 
between E10.5 to E12.0. Kidney pairs from embryos carrying the Hoxb7-GFP 
transgene (heterozygous) were used to visualise the ureteric epithelial system 
(A-D). Wild-type embryos were used for Grem1 and Bmp7 in situ hybridization 
(E-H and M-P respectively). Bmp4 expression was assessed by X-gal staining 
of kidneys carrying the Bmp4∆–lacZ allele (I-L). Grem1 transcripts were detected 
in the metanephric mesenchyme and mesenchymal cells surrounding the 
Wolffian duct (E-H). As the ureteric bud is emerging from the Wolffian duct and 
elongates to form the ampullae, Grem1 expression becomes stronger around 
the ureteric bud tip (E-F). Once epithelial branching occurs, Grem1 is detected 
in the metanephric mesenchyme around the tips of the branched ureteric 
epithelium (G-H) – note that Grem1 expression is maintained in the mesenchyme surrounding the Wolffian duct. β-galactosidase activity reveals the Bmp4 
transcript distribution (I-L). Bmp4 expression is detected in the ventral mesenchyme of the kidney rudiments and delineates the Wolffian duct. The 
mesenchyme surrounding the ureteric bud lacks Bmp4 (I), as it gives rise to the ampullae (J), and branches (K-L). Bmp7 transcripts are expressed in a 
pattern similar to Grem1 transcripts (compare M-P with E-P). Bmp7 is expressed by the mesenchymal cells adjacent to the Wolffian duct and in the 
metanephric mesenchyme. At the earlier stages (M-N) Bmp7 expression is more pronounced in the metanephric mesenchyme. Bmp7 transcripts are also 
detected in the metanephric mesenchyme surrounding the branched ureteric tips and the expression is maintained around the Wolffian duct (O-P).    
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Discussion 
The main aim of the present study was to genetically analyse the  
GREM1/BMP7 interactions. It was important to assess if GREM1 antagonises 
also BMP7 which had previously been shown to be also required for normal 
kidney development (Godin et al., 1998; Jena et al., 1997). 
In contrast to Bmp4 (Michos et al., 2007), Bmp7 must be completely inactivated 
to restore the disruption of UB outgrowth in Grem1 deficient kidneys. In 
particular, RET signalling is restored in double mutant embryonic kidneys, which 
suggested that GDNF/RET signalling was re-established. This was confirmed 
by restricted Wnt11 expression in Grem1∆/∆; Bmp7∆/∆ kidney rudiments. If both 
Ret and Wnt11 are normally expressed, then the GDNF/RET/WNT11 signalling 
loop must be restored as it is required to propagate branching morphogenesis 
(Majumdar et al., 2003). Furthermore, normal induction of kidney development 
was further supported by the restored Pax2 expression, both in the epithelia 
and condensing mesenchyme. These results, together with the fact that PAX2 
is required for activation of GDNF via enhanced RET activity (Brophy et al., 
2001; Brophy et al., 2003), show that the kidney rudiments are competent to 
initiate ureteric bud branching morphogenesis.  
Furthermore, Six2 expression is restored at early stages in the Grem1∆/∆; 
Bmp7∆/∆ kidney rudiments indicative of survival of the mesenchymal nephron 
progenitors in contrast to Grem1 mutants. In fact also the premature depletion 
of these progenitors in Bmp7∆/∆ mutants is partially restored in double mutants. 
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Although Grem1; Bmp7 double mutant kidneys display a hypoplastic phenotype 
due to the fact that at later stages, the Six2 expression is also lost similarly to 
Bmp7 deficient kidneys. However, morphogenesis of Grem1∆/∆; Bmp7∆/∆ 
kidneys is improved in comparison to Bmp7 deficient kidneys. First of all, 
hydroureter formation is suppressed in double mutant kidneys. Second, fewer 
and smaller cysts were observed in Grem1∆/∆; Bmp7∆/∆ kidneys. Thirdly, the 
thickness of the cortex is increased and morphologically more normal glomeruli 
form. Based on these details we may state that Grem1 inactivation does 
improve the Bmp7 deficiency even at more advanced stages. 
I propose that not GREM1 mediated antagonism of a particular BMP ligand, but 
spatiotemporally controlled reduction of BMP activity is key to initiation and 
progression of kidney morphogenesis. This study reveals an early function for 
Bmp7 as it is clearly co-expressed with Grem1 and its activity must be 
negatively regulated by GREM1 as revealed by the excess of BMP signal 
transduction in Grem1 deficient embryonic kidneys. The possible 
GREM1/BMP7 agonistic interaction might be a consequence of heterodimer 
formation. In Xenopus BMP4-BMP7 heterodimers have a potent mesoderm 
inducing capability, which is stronger than the one of BMP4 and BMP7 
homodimers respectively (Suzuki et al., 1997). It has also been suggested that 
BMP4-BMP7 heterodimers exist in the mouse as mice heterozygous for both 
Bmp4 and Bmp7 display minor skeletal defects (Katagiri et al., 1998). Although 
the existence of BMP4-BMP7 heterodimers has not been demonstrated in vivo, 
this partially shows why GREM1 also antagonises BMP7 at an early stage. This 
could be similar to the situation in limb buds, where additional inactivation of 
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Bmp7 also contributes to restoration of digit development in Grem1∆/∆ embryos 
(Bénazet et al., 2009). Considering that Grem1 and Bmp7 are spatiotemporally 
co-expressed in the early kidney metanephric mesenchyme, it is plausible that, 
while BMP4-BMP7 heterodimers are antagonised by GREM1, BMP7 
homodimers are not. As I have already indicated, GREM1 preferentially 
antagonizes BMP4. Hence, the antagonistic effect GREM1 exerts on the BMP4 
homodimers and potential BMP4-BMP7 heterodimers might favour the BMP7 
homodimers to exert their function on e.g. Six2 positive nephrogenic progenitors  
Another major finding was that Grem1 inactivation prevents to some extent the 
glomerulosclerosis, hydroureters and cyst formation observed in Bmp7 deficient 
embryonic kidneys. However, the impairment of kidney organogenesis in 
Grem1; Bmp7 double mutant embryos is a likely consequence of Six2 down-
regulation. Six2 deficient kidneys lose their nephron progenitor pool by 
apoptosis, revealing the essential role of Six2 in maintaining the metanephric 
mesenchyme in an undifferentiated state (Self et al., 2006). This results in 
premature nephrogenesis and small kidney size due to the metanephric 
mesenchyme cell death.  
In summary this study provides a first glimpse into the intricate regulation of 
BMP activity (as the sum of BMP4 and BMP7 activities) during initiation and 
progression of metanephric kidney organogenesis. 
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IX. CONCLUSION AND OUTLOOK 
 
This section aims to combine the main outcomes described in the different 
chapters. None of them should be considered as independent studies, but 
rather as an effort to achieve the main goal of this thesis, namely to analyse the 
BMP-Gremlin1 antagonistic interactions. 
 
GREM1 is a crucial renal BMP signalling antagonist, required for initiation of 
ureteric bud (UB) outgrowth and epithelial branching morphogenesis (Michos et 
al., 2007). The BMP signalling activity, with particular emphasis on BMP4, is 
regulated by GREM1 in a precise spatiotemporal context. Grem1 deficient 
kidney rudiments cultured with recombinant GREM1 displayed a restoration of 
UB outgrowth and epithelial branching. Both Gdnf mesenchymal expression 
and Wnt11 expression at the epithelial tips were restored by culturing Grem1 
deficient kidney rudiments with recombinant GREM1. Genetic and molecular 
studies have shown that reduction of BMP4 activity by GREM1 enables the 
epithelial-mesenchymal GDNF/WNT11 feedback signalling loop essential for 
UB initial outgrowth and epithelial branching. These studies provided insight into 
the mechanisms that mediate the first steps required for metanephric 
mesenchyme invasion by the UB, which is the first step in metanephric kidney 
development.  
 
However also BMP7 activity is modulated by GREM1 as complete inactivation 
of Bmp7 in a Grem1 deficient background also permits initiation of ureteric bud 
outgrowth and epithelial branching morphogenesis. Furthermore, the Grem1 
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inactivation is not sufficient to restore the depletion of Six2 positive 
mesenchymal progenitors which characterize the Bmp7 deficient hypoplastic 
kidney phenotype. As aspects of collecting duct morphogenesis were restored, 
Grem1 may normally also function after initiation of UB outgrowth in structures 
such as the collecting ducts system and the glomeruli. Moreover, at least at an 
early stage, GREM1-BMP7 interactions may not be merely antagonistic. The 
BMP7 activity may actually benefit from a BMP4 zone generated by GREM1 
mediated BMP4 antagonism via formation of alternative BMP heterodimers, 
which may alter receptor-ligand interactions (as previously suggested by BMP7 
and BMP2 co-localization analysis (Lyons et al., 1995).  
 
Recently, miRNAs binding sites were identified in the Grem1 promoter, which 
reveals another level of regulating Grem1 expression (Walsh et al., 2008). 
Grem1 is not only expressed during onset of kidney development but also 
during renal injury (McMahon et al., 2000; Walsh et al., 2008). Therefore, the 
regulation of Grem1 expression during normal kidney development, which is 
largely unknown, and renal injury must be analysed in detail. 
 
While these genetic studies reveal that GREM1 antagonises BMP4 to a larger 
extent than BMP7 or BMP2 during limb and kidney development (Bénazet et al., 
2009) it appears as a key gate keeper of overall BMP activities during the 
development of these structures. These results may also be relevant to 
developing novel tissue engineering strategies. 
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APPENDIX 1. TM-CRE MEDIATED INACTIVATION OF BMP4 DURING 
KIDNEY DEVELOPMENT 
  
Introduction 
GREM1-mediated inhibition of BMP4 activity in the metanephric mesenchyme is 
required for initiation of UB outgrowth and subsequent branching 
morphogenesis. Furthermore, it has also been shown that GREM1 treatment of 
cultured kidney rudiments leads to the formation of ectopic UBs (Michos et al., 
2007). The observed phenotype was possibly due to the abnormal overall 
down-regulation of BMP signalling. I wanted to address the following questions: 
1) was the ectopic bud formation the result of direct antagonism of BMP4 as 
suggested by the analysis of Grem1; Bmp4 compound mutant embryos and; 2) 
were the supernumerary ectopic UBs able to initiate branching morphogenesis. 
To investigate these issues, Bmp4 was completely inactivated using tamoxifen-
CRE mediated gene inactivation. 
 
Methods and Aims 
Tamoxifen-CRE meditated gene inactivation provided results for both limb and 
kidney development. This appendix will focus on the investigation of Bmp4 
inactivation during early metanephric kidney development. The methods are 
described in the ‘Material and Methods’ chapter. Early inactivation of Bmp4 in 
vivo was accomplished by injecting tamoxifen into pregnant Bmp4f/f females 
mated previously with Bmp4∆/+; Tm-Cret/+ males. To assess the TM-Cre 
mediated inactivation in all embryonic tissues, pregnant Bmp4f/f females were 
119 
 
 
injected with tamoxifen and embryos were collected 15-20 hours later for β-
galactosidase staining. Injection at around E9.25 – E9.5 resulted in complete 
recombination before 33 somites - (Sup. Fig.1C – compare with Sup. Fig.1B). 
Pregnant females where injected when embryos had developed to about E8.75 
to E9.5. Embryos were collected at E11.5 and kidneys isolated for molecular 
analysis. Mice of the same genotypes were also used to collect kidneys 
rudiments to be used for 4OH-TM mediated inactivation of Bmp4 in culture. 
Embryonic kidneys were cultured for 48 hours prior to molecular analysis.  
 
Results 
Bmp4 was conditionally inactivated using a uniformly expressed TM-Cre line. 
4OH-TM tamoxifen mediated inactivation of Bmp4 in culture reveals effects on 
kidney branching morphogenesis (Fig. 1A’-E’). Ret is expressed by the UB tips, 
which allowed us to trace the resulting branching pattern (Fig. 1A-E). A 
schematic representation (Fig. 1A’ to 1E’) reveals that Bmp4f/+ and Bmp4∆c/+; 
Tmt/+ kidney rudiments (Fig.1A-B) develop with normal branching pattern as 
expected. Reduction of BMP4 activity as is the case in Bmp4∆/f kidney 
rudiments allows branching morphogenesis to progress normally but the 
elongation of the ureteric bud is affected (compare Fig.1C and Sup. Fig. 1A-C 
with Fig. 1A, B). Complete inactivation of Bmp4 in Bmp4∆/∆c; Tmt/+ kidneys (Fig. 
1D, E) resulted in formation of ectopic UBs (Fig. 1D’ and E’). Inactivation of 
Bmp4 also caused variable branching such that the endogenous ureteric bud 
(red) of the kidney rudiment in Fig. 1D’ only branched once in contrast to the 
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one shown in Fig. 1E’ (branched 3 times). Furthermore, ectopic buds emerged 
from the Wolffian duct of both Bmp4∆/∆c; Tmt/+ kidneys. Only one ectopic ureteric 
bud formed in one (Fig. 1E’) while several formed in the other case (Fig. 1D’). 
This might be due to the fact that one embryo (Fig. 1D) was significantly 
younger (41 somites) than the other (Fig. 1E ; 49 somites). Bmp4 inactivation at 
earlier stages might therefore promote formation of more ectopic UBs. No 
ectopic UBs were seen in controls and embryonic kidneys cultured without 
4OH-tamoxifen (compare Fig. 1D, E to Fig. 2D, E). Furthermore, culture of 
Bmp4∆/f kidney rudiments in medium with 4OH-tamoxifen did not cause 
formation of ectopic buds (Fig. 1C and Fig. 2A, B).  
To study the effects of in vivo Bmp4 inactivation during early metanephric 
kidney development, pregnant Bmp4f/f females were injected with tamoxifen 
around E9.5-E9.75 and embryos were collected 48 hours later. Initial analysis 
revealed about 50% lethality of the Bmp4∆/∆c; Tmt/+ embryos while the overall 
lethality was about 23% (Table 1). Analysis of Ret expression showed that an 
ectopic UB emerged from the Wolffian duct in 1 out of 2 Bmp4∆/∆c; Tmt/+  
embryos (Fig. 1I, J) while this was never the case in controls. Similarly, analysis 
of Pax2 revealed ectopic UBs in Bmp4∆/∆c;TMt/+ in 1 of 2 kidney rudiments (Fig. 
1N ,O). I also noted that the formation of ectopic buds (Fig. 1J, O) was 
paralleled by developmental retardation of kidney development. 
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Fig.1. Bmp4 inactivation mediated by tamoxifen induced 
recombination reveals the BMP4 early requirement towards 
ureteric bud elongation and branching morphogenesis, 
highlighted by the Ret and Pax2 endogenous and ectopic 
expression domains.  
Mouse embryonic kidneys collected at E11.25-11.5 (41-49 
somites) and cultured with 4OH-TM during 48 hours (A,-E). Upper 
panels represent the schematic tracings of the Wolffian duct and 
ureteric epithelium. Wolffian duct and endogenous ureteric bud 
(white) and ectopic ureteric buds (yellow) – the first branch in red; 
second branch in blue; third branch in green; fourth branch in 
purple (A’- E’). Mouse kidney rudiments isolated from tamoxifen 
injected females at E11.5. White asterisks indicate endogenous 
ureteric buds and the yellow asterisks the ectopic epithelial buds 
(F – O). Ret expression is detected along the Wolffian duct and tips of the ureteric buds (F-J) while Pax2 expression is detected in the mesenchyme 
surrounding the Wolffian duct and metanephric mesenchyme around the ureteric bud epithelia (K-O). Note the ectopic epithelial bud tip expressing Ret (J) 
and the Pax2 expression in the metanephric mesenchyme surrounding the ectopic ureteric buds. (O). From all viable Bmp4∆/∆c ; Tmt/+ embryos (17), 10 were 
used for the present analysis and displayed ectopic buds in 50% of the cases. Scale bars, 200µm. 
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Genotypes Collected 
Embryos 
   Viable 
Embryos 
Genotype Specific         
       Lethality 
    
Bmp4∆/∆c ; Tmt/+      35  17              50% 
Bmp4∆/f 
Bmp4∆c/+ ; Tmt/+ 
     38 
     53 
  31    
  44    
          18% 
          17% 
Bmp4f/+ 
 
     38   34              11% 
Total    164  126  (77%)           
 
Table 1 – Genetic analysis of TM mediated Bmp4 inactivation. The embryonic viability upon 
tamoxifen injection was 77% while the remnant 23% may be attributed to the technique itself 
or/and to the embryonic development variability that lead to an early Bmp4 inactivation still at a 
critical stage. Note that Bmp4∆/∆c ; Tmt/+ lethality was 51% while the Bmp4∆/f was only 18%. The 
overall 11% lethality observed in the Bmp4f/+ embryos can be recognized as the tamoxifen 
injection derived mortality. 
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Fig.2. Cultured Bmp4D/f kidney rudiments never displayed the formation of supernumerary ectopic ureteric buds.  
Mouse embryonic kidneys collected at E11.25-11.5 (41-49 somites), obtained from littermate embryos displayed in figure 1. The Ret in situ hybridization 
allowed the identification of the ureteric bud tips (A-E). Compare the kidney rudiments cultured for 48 hours with 4OH-TM (A, B) with the control culture 
without 4OH-TM (C-E).  Note that the Bmp4∆/f ; TMt/+ kidneys do not display any abnormal ectopic ureteric buds. Upper panels represent the schematic 
tracings of the Wolffian duct and ureteric epithelium. Wolffian duct and endogenous ureteric bud (white) and ectopic ureteric buds (yellow) – the first branch in 
red; second branch in blue; third branch in green (A’- E’). Scale bars, 200µm. 
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Conclusion 
Both in vivo and in vitro tamoxifen mediated Bmp4 inactivation revealed its 
requirement for restriction of UB formation to one site. Although ectopic UB 
were only observed in 50% of the embryonic kidneys, culturing of kidney 
rudiments with recombinant GREM1 resulted in formation of supernumerary 
ectopic UBs in 75% of all cases (12 out of 16) (see chapter VII). Therefore, it is 
safe to conclude that the GREM1-mediated reduction of BMP4 activity results in 
formation of ectopic buds along the Wolffian duct. None of the observed ectopic 
buds resulting from Bmp4 inactivation initiated proper branching 
morphogenesis, which differs from the effects of treatment with GREM1. 
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Sup. Fig.1. Cre recombinase mediated inactivation of Bmp4 (B4) is monitored by 
activation of the LacZ cassette. 
LacZ staining to monitor TM-Cre mediated inactivation of the Bmp4loxP-lacZ allele in the entire 
embryo. Embryos were harvested 15-20hrs after one tamoxifen injection into pregnant mothers 
at about E8.75. Embryo dorsal view at the level of the forelimb (A-C). Recombination appears 
complete prior to E9.0 (22 somites, panel B – compare with A). (C) TM injection at around 
E9.25 results in complete recombination prior to E10.25 (33 somites). D: dorsal; V: ventral (from 
Bénazet et al., 2009). 
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APPENDIX 2. MICROARRAY ANALYSIS OF THE GREM1-BMP4 
ANTAGONISTIC INTERACTIONS 
  
Introduction 
The kidney agenesis phenotype caused by inactivation of Grem1 can be 
restored by additional inactivation of one Bmp4 allele. However, further studies 
were required to understand how excessive BMP signalling blocks UB 
outgrowth and how restoration of UB outgrowth is molecularly controlled. To 
gain insight into those events, a microarray gene expression analysis was 
performed. Microarray technology measures transcript levels in cells of a 
particular tissue and is often used to identify genes functioning in a particular 
tissue/process. The microarray analysis of Grem1∆/∆ and Grem1∆/∆; Bmp4∆/+ 
kidney rudiments identified molecular novel components of the morpho-
regulatory mechanisms controlling branching. 
 
Methods and Aims 
The microarray analysis aimed to assess transcript levels at a very precise 
developmental stage, between the UB ampullae and T-shape stages. Kidneys 
were isolated at 47-48 somites stage, before nephrogenesis had started. The 
gender of all embryos was determined to circumvent sex specific fluctuations in 
gene expression. The selection of male samples was unbiased and mainly the 
consequence of both developmental stage and gender availability. RNA was 
isolated from the collected kidney rudiments and processed according the 
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standard GeneChip® protocol. Upon scanning of the hybridized chips, data 
were statistically validated using the Genedata Expressionist® analysis 
programme. Expression values were normalized and N-Way ANOVA tests 
filtered results with a p-value of ≤ 0.05 (95% confidence). To further restrict the 
analysis but retain the already validated results, a minimal fold change filter was 
applied. The resulting list, after removal of the internal GeneChip® controls, was 
used for Ingenuity® pathway analysis. A modified BMP pathway was built by 
integrating the discovered pathways nodes intersecting with the BMP signalling 
pathway based on the biological relationships. Select genes were then verified 
by in situ hybridization analysis. 
 
Results 
The N-Way ANOVA 0.05 p-value restriction resulted in a list of 411 differentially 
hybridizing transcripts. This transcripts list was used for Ingenuity® pathway 
analysis. The BMP signaling network was used as a scaffold and the network 
was expanded to discover potentially affected pathways due to altered BMP 
signalling (Fig. 1). The genes list identified by the Ingenuity® BMP pathway 
analyses is shown in Table 1. Analysing Grem1∆/∆  versus wild-type kidneys 
allowed me to focus my attention on the underlying molecules and signalling 
complexes (Fig. 1 – colour ellipses highlight the molecular modules).  
The direct relationship between GREM1 and BMP4 was immediately 
recognized (Fig. 1 – blue ellipse) and the identified genes behaviours 
correspond to the already known interactions. Grem1 expression was still 
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detected in the Grem1∆/∆ samples because the Grem1 knock-out targeted exon 
2 specifically (Michos et al., 2004) while Affymetrix GeneChip array probes 
cover the entire gene. The GDNF/RET signalling pathway was also evidenced 
(Fig.1 – yellow ellipse) and although Ret was not shown as significantly 
changed, Gfra1, the co-receptor, was identified as altered. Gfra1 was down-
regulated to 0.69-fold in the Grem1∆/∆ kidney rudiments. Conversely, Gfra1 was 
up-regulated to 1.6 fold Grem1∆/∆; Bmp4∆/+ kidney rudiments when compared to 
Grem1 deficient kidney rudiments.  
Although the FGFR interactions, highlighted by the red ellipse (Fig. 1), did not 
show any variation in expression levels, indirect transcriptional alterations were. 
Expression of the Etv4 and Etv5 transcription factors transcriptionally regulated 
by FGFs in several organs including the kidney (Firnberg and Neubüser, 2002; 
Liu et al., 2003; Lu et al., 2009) is altered. Etv4 and Etv5 are down-regulated in 
Grem1∆/∆ kidney rudiments 0.68 and 0.75 fold respectively (Table 1) while Etv4 
is up-regulated 1.48 fold in Grem1∆/∆; Bmp4∆/+  kidney rudiments. In contrast, 
Etv5 is restored to wild-type expression levels (1,08 fold) in Grem1∆/∆; Bmp4∆/+ 
kidney rudiments. 
Six2 is down-regulated 0.67-fold in Grem1∆/∆ in comparison to wild-type 
expression kidney rudiments. A 1.91-fold up-regulation was detected in the 
Grem1∆/∆; Bmp4∆/+ in comparison to Grem1∆/∆, while a 1.29 fold change was 
observed in comparison to wild-type kidney rudiments (Fig. 2B).  
Both Etv4 and Six2 expression patterns were assessed by mRNA in situ 
hybridization and confirmed the microarray analysis (Fig. 2A, compare with the 
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expression values in B). Six2 expression is slightly reduced in Grem1∆/∆ while it 
was clearly up-regulated in Grem1∆/∆; Bmp4∆/+ kidney rudiments. Etv4 was 
clearly down-regulated in Grem1 deficient kidneys and up-regulated following 
additional inactivation of one Bmp4 allele. 
Several other genes identified by the microarray analysis have not yet been 
analysed further. 
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Fig.1. Network analysis of the alterations in gene expression 
between Grem1∆/∆ and wild-type kidney rudiments. The 
Ingenuity® canonical BMP pathway network was expanded to 
discover potentially linked pathways. The network is displayed 
graphically as nodes (genes/gene products) and edges. Intensity 
of the node colour indicates the degree of up-regulation (red) or 
down-regulation (green). Node shapes represent the functional 
class of the gene products (square, cytokine; vertical oval, 
transmembrane receptor; rectangle, nuclear receptor; diamond, 
enzyme; rhomboid, transporter; hexagon, translation factor; 
horizontal oval, transcription factor; and circle, other). Edges 
labels indicate relationships: — binding only; → acts on. The 
length of an edge reflects the node-to-node relationship. Dotted 
edges represent indirect interactions. The coloured ellipses 
indicate different signalling modules responding to the alterations 
in BMP signalling. BMP signalling in blue, GDNF/Ret in yellow, 
ETV4/5 in purple and FGF in red. 
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Fig.2. Whole-mount in situ detection of the Six2 and Etv4 mRNAs validates the 
microarray transcripts identification criteria. 
Mouse embryonic kidneys collected at E11.5 (48-51 somites). (A) Six2 expression is detected in 
the metanephric mesenchyme around the epithelial ureteric bud while Etv4 is expressed in the 
ureteric bud epithelia and metanephric mesenchyme (the gonads also express Etv4 whose 
detection is weakly observed along the Wolffian duct epithelia as well). (B) Six2 and Etv4 
expression intensity values and fold-change variation among the different genotypes. Note that 
while it is obvious that Etv4 is down-regulated and restored, Six2 down-regulation is not so 
obvious but the up-regulation is clear and possibly due to the expansion of the metanephric 
mesenchyme compartment. 
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Conclusion 
The microarray analysis of genes altered in Grem1∆/∆ and restored in Grem1∆/∆; 
Bmp∆/+ kidney rudiments provided evidence for interconnected pathways. The 
immediate examination yielded surprisingly few altered genes. The second 
important finding was the identification of Six2 and Etv4/5 as altered genes. The 
identification of Six2 correlates with the depletion of nephrogenic progenitors in 
Grem1∆/∆ embryonic kidneys, in agreement with the fact that Six2 is required to 
regulate the nephron progenitor pool within the metanephric mesenchyme 
(Kobayashi et al., 2008). The identification of the Etv4/5 transcription factors 
correlates with their recently demonstrated requirement for kidney branching 
morphogenesis, downstream of GDNF-Ret signalling (Lu et al., 2009).    
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Table 1: Genes identified in the Ingenuity® BMP signalling pathway analysis. All genotype classes and relative fold changes were considered.
Genes WT Grem1∆/∆ Grem∆/∆;Bmp4∆/+ 
Fold change  
Grem1∆/∆ / WT 
Fold change  
Grem∆/∆;Bmp4∆/+ / Grem1∆/∆ 
Fold change 
 Grem∆/∆;Bmp4∆/+ / Wt 
Agtr2 528,6041 423,9591 416,1042 0,802035209 0,981472505 0,787175506 
Avpr1a 98,41199 78,33794 83,89924 0,796020282 1,070991144 0,852530672 
Bmp4 621,0085 532,8455 373,1586 0,858032539 0,700312942 0,600891292 
Bmp5 520,4172 493,9408 410,9665 0,949124664 0,832015699 0,789686621 
Bmper 676,3885 734,0994 578,9975 1,085322119 0,788718122 0,856013223 
Cxcr4 458,8655 360,5381 469,4916 0,785716294 1,302196911 1,02315733 
Etv4 141,2644 96,68702 143,3359 0,6844401 1,482473035 1,014663992 
Etv5 267,4216 201,5314 217,9943 0,753609282 1,081689007 0,815170876 
Fmod 177,7714 152,641 136,3835 0,858636429 0,893491919 0,76718471 
Gdnf 162,9293 135,6146 170,591 0,832352438 1,257910284 1,047024691 
Gfra1 322,0566 221,1384 354,3294 0,686644521 1,602297023 1,100208473 
Grem1 119,4658 96,53632 94,60455 0,808066576 0,97998919 0,791896509 
HCG 1757335 (Rap1a) 399,8005 481,2827 484,4134 1,203807149 1,006504909 1,211637804 
Msx2 105,9559 100,29 83,52566 0,946525866 0,83284136 0,78830589 
NfIA 360,0708 300,7293 259,1877 0,835194912 0,861863809 0,719824268 
NfIB 1103,947 914,6273 867,8156 0,828506532 0,948818825 0,786102594 
Pax2 205,4109 157,0658 223,278 0,764641993 1,42155708 1,086982239 
Pdgf 117,1343 101,2776 87,77714 0,864628038 0,86669846 0,749371789 
Pebp1 688,5453 717,0482 865,3643 1,041395824 1,20684258 1,256800823 
Ptk2b 135,2831 116,3346 106,5724 0,859934463 0,916085154 0,787773196 
Rap1 399,8005 481,2827 484,4134 1,203807149 1,006504909 1,211637804 
Rassf4 135,0365 94,11868 108,4451 0,696986963 1,152216542 0,803079908 
Rrs1 234,9687 278,8754 295,2354 1,18686191 1,058664192 1,256488205 
Ssp1 84,90002 88,09121 68,85815 1,037587624 0,781668795 0,811049868 
Tatf4b 92,66903 73,92025 85,89431 0,797680196 1,161986195 0,926893375 
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